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ABSTRACT OF THE DISSERTATION 
 
Microgravity Exerts an Age-Dependent Effect on  
Cardiovascular Progenitor Cell Development 
 
by 
 
Jonathan Baio 
 
Doctor of Philosophy, Graduate Program in Anatomy 
Loma Linda University, June 2018 
Dr. Mary Kearns-Jonker, Chairperson 
 
 
The heart and its cellular components are profoundly altered by missions to space 
and injury on Earth. Increasing evidence has identified that one such alteration induced 
by spaceflight is the promotion of the efficacious use of stem cells in therapies on Earth. 
For this reason, neonatal and adult human cardiovascular progenitor cells (CPCs) were 
cultured aboard the International Space Station (ISS). Subsequently, we assessed the 
effects of mechanical unloading on developmental properties and signaling. Spaceflight 
induced the expression of genes that are typically associated with an earlier state of 
cardiovascular development. In particular, in neonatal CPCs, we measured increased 
expression of pre-cardiac and developmental regulatory (Bmp and Tbx) genes; decreased 
expression of mesodermal derivative markers, including endothelial tube formation; and 
enhanced proliferative potential, as indicated by cell growth and cell cycle analysis. 
Interestingly, these changes were not observed in adult CPCs. To understand the 
mechanism by which such changes occurred in neonatal CPCs, we assessed the 
expression of mechanosensitive small RhoGTPases. Given the effect of these molecules 
on intracellular calcium levels, we evaluated changes in non-canonical Wnt/calcium 
signaling. ISS-cultured CPCs exhibited elevated levels of calcium handling and signaling 
 xviii 
genes, which corresponded to activation of protein kinase C alpha (PKCα), a calcium-
dependent protein kinase, and Akt, a regulator of stem cell self-renewal, after 30 days. To 
explore the effect of calcium induction in neonatal CPCs, we activated PKCα using 
hWnt5a treatment on Earth, which resulted in an induction of early cardiovascular 
developmental marker expression. Interestingly, markers of the sinoatrial node, which 
may represent embryonic myocardium maintained in its primitive state, were induced by 
culture of neonatal CPCs aboard the ISS, which was modeled on Earth, at least in part, 
using the calcium signaling activators angiotensin II and hWnt5a. To test whether such 
signaling could induce sinoatrial nodal gene development on Earth, we treated neonatal 
CPCs with angiotensin II and observed the reliable induction of a sinoatrial nodal 
phenotype. We found that, in neonatal CPCs, spaceflight induces PKCα and Akt 
signaling, promotes the induction of an earlier developmental state, and highlights 
signaling events that may underpin biological pacemaker development on Earth.  
 
 1 
CHAPTER ONE 
INTRODUCTION 
 
Heart failure impacts 2% of adults in developed countries (McMurray, 2005) and 
results in death within one year in 35% of patients (National Clinical Guideline Centre, 
2010). There is no cure for heart failure and so treatment relies upon symptom 
management and the prevention of disease progression. Heart failure can arise due to 
myocardial infarction, in which the working myocardium dies following artery blockage 
and reduced access to nutrients and oxygen. Since the human heart lacks a significant 
natural capacity to regenerate injured or damaged heart muscle (Kikuchi et al., 2012), 
injuries to cardiac tissue often significantly impact a person’s quality of life. In an effort 
to identify methods to repair damaged myocardium, the transplantation of cardiovascular 
progenitor cells (CPCs), which retain the ability to differentiate into heart muscle tissue, 
has been the subject of intensive research. As these studies have evolved, their use in 
engineering other cardiovascular tissue, such as a biological pacemaker, has progressed 
as well. Ultimately, research into the biology of CPCs will yield important insights into 
novel treatments for cardiac repair. 
 
Progenitor Cells for Cardiovascular Repair 
Cardiovascular progenitor cells represent a population of multipotent stem cells 
that reside in the heart through adulthood and exhibit an ability to differentiate into 
various cardiovascular lineages. CPCs can be derived from primary sources, including 
the human heart, or can be induced via small molecule-mediated differentiation of 
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pluripotent or embryonic stem cells, with several markers having been identified on these 
cells (Table 1).  
Cardiovascular progenitor biology is intimately related to the molecular processes 
that guide the development of cardiac tissue. Yet, given the complexity of cardiovascular 
development, there are several markers that can be used to identify various 
cardiovascular precursor cells in vitro, as shown in Table 1. In these studies, various 
methods have been used for the selection of cell markers, including magnetic bead 
sorting for a particular marker (e.g., PDGFRα in Chong et al. (2013) or c-Kit in Li et al. 
(2012)). Thus, these reports are limited in their ability to discuss the levels of expression 
of the identified markers beyond what is detectable using their specified system of 
isolation. Accordingly, it is possible that such studies excluded cell types that expressed 
these markers at lower levels. As we discuss later, the overlap in developmental staging 
and marker expression documented in the studies included in Table 1 may be clarified by 
a greater understanding of the molecular markers of the various stages of cardiogenesis 
and the pathways used to drive this process.  
Notably, controversy still exists regarding the true constitution of a cardiac 
progenitor. One laboratory concluded that “resident c-kit(+) cells in the heart are not 
cardiac stem cells” based upon the inability of c-kit-labeled cells to co-localize with 
Nkx2.5 or develop into cardiomyocytes that express troponin T (Sultana et al., 2015). 
Meanwhile, lineage tracing of progenitors that express Isl1, a LIM homeodomain 
transcription factor, indicated that Isl1-positive cells give rise to the outflow tract, right 
ventricle, and much of the atria in the developed heart (Cai et al., 2003).  
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Table 1. Cell types identified or speculated as being cardiovascular progenitors  
Abbreviations: CPC, cardiovascular progenitor cells; CXCR4, C-X-C Motif Chemokine 
Receptor 4; ESC, embryonic stem cells; KDR, kinase-insert domain receptor; MESP1, 
mesoderm posterior protein 1; PDGFR, platelet-derived growth factor receptor alpha; 
SCA-1, stem cell antigen-1; SSEA-1, stage-specific embryonic antigen 1 
  
Progenitor Name Expression Profile Reports 
Cardiospheres CD34-/45- 
Central: c-kit+/Nkx2.5+ 
Peripheral: CD31+/90+/105+/133+ 
Davis et al., 2009 
 
 
 
Cardiosphere-derived c-Kit+/CD29+/90+/105+/45-/34-/31-/133- Li et al., 2012 
c-kit+  c-kit+  
 Vascular: KDR+/CD31+ 
 Myogenic: αSA+/- 
 
Sandstedt et al., 2010 
Bearzi et al., 2009 
 
Isl1+/c-Kit+ Fetal  Isl1+/c-Kit+ Serradilfalco et al., 2011 
 
Isl1+/c-Kit+ Neonatal  
& Adult  
 
Isl1+/c-Kit+/SSEA-1+/ 
MESP1+/PDGFRα+/ 
KDR+/CXCR4+/CXCR7+ 
 
Fuentes et al., 2013 
Baio et al., 2018 
 
 
Isl1+ hESC-derived 
 
Isl1+/Nkx2-5+/KDR+/CD82+ 
Gata4+/Tbx1+/Tbx20+ 
 
Moretti et al., 2006 
Takeda et al., 2018 
 
Sca-1+ 
 
Sca-1+/GATA4+/NKX2-5+/- 
c-Kit+/-/cd31- 
 
Oh et al., 2003 
Wang et al., 2006 
 
SSEA-1+ hESC-
derived  
 
SSEA-1+/MESP1+/Oct4+ 
SSEA-1+/Isl1+ 
 
 
Blin et al., 2010a 
Menasché et al., 2015 
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While both c-Kit and Isl1 are expressed during the process of cardiogenesis, their co-
expession with additional markers allow for a more precise definition of the 
developmental staging of the cell under study. Furthermore, several of the markers 
defined above may also be helpful in identifying a population of cardiovascular 
progenitors that exhibit enhanced efficacy in repair, as discussed below. These 
considerations first require a brief review of the anatomical and molecular events 
underpinning heart development.  
 
Cardiovascular Development 
The Heart Fields 
The broad pattern of human heart formation has been well known for decades. 
Following gastrulation, two, bilateral populations of cranial lateral plate mesoderm 
develop and fuse at the midline to form the primitive heart tube (Mjaatvedt, 2001). The 
cardiogenic mesoderm that forms this primitive heart tube is termed the primary heart 
field. In the early 2000s, a second region of pharyngeal mesoderm was observed to 
contribute to the elongation of the heart tube. This region, the second heart field, gives 
rise to tissue that is found at the inflow tract, including parts of the atria and, perhaps, the 
sinoatrial node (SAN). Notably, the origins of the SAN are still the subject of intensive 
debate. Indeed, an avian model of cardiovascular development demonstrated that the 
SAN uniquely arises from the “tertiary heart field,” or a mass of mesoderm that is not 
located within, but rather posterior to, the second heart field (Bressan, 2013).  
Following the linear heart tube stage (i.e., prior to heart tube looping), the second 
heart field also contributes to the outflow tract (Kelly, 2012). Cranial and caudal folding 
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moves this anteriorly-located cardiogenic plate to the region of the putative thorax. Due 
to restrictions on growth that are conferred by both the persistence of dorsal mesocardium 
as well as the developing body walls and diaphragm, the heart tube begins to loop, 
ultimately forming the inverted, multi-chambered conical shape. Importantly, neural crest 
cells from the fourth and sixth pharyngeal arches migrate and transform into mesenchyme 
to contribute to the development and septation of the outflow tract of the heart 
(Bradshaw, 2009). Therefore, in addition to the tissue of the mesoderm-derived primitive 
heart tube and of the second heart field, ectoderm-derived, neural crest tissue also 
contributes to heart formation (Sadler, 2012).  
Throughout this process, nearby tissues secrete morphogens, thereby establishing 
gradients that modulate heart formation. Briefly, lateral ectoderm and endoderm secrete 
FGFs and BMPs that support cardiac growth ventrally while neuroectoderm-derived 
WNT inhibits cardiac growth dorsally (Bruneau, 2012). This process of gross, anatomical 
cardiogenesis is driven by an underlying cascade of molecular events.  
 
Molecular Cardiogenesis 
This gradient of morphogens is intimately involved in the molecular events that 
drive heart formation. An abbreviated version of the molecular events driving 
cardiogenesis from a pluripotent state is shown in Figure 1 (Gessert & Kühl, 2010; den 
Hartogh et al., 2015). Progenitor cells used in cardiac stem cell therapies (Table 1) reflect 
a particular stage of development and thus are limited in their potential applications. As 
discussed below, consideration of the developmental staging of the progenitor used for 
transplantation is related to the efficacy of treatment. The schematic shown herein is a 
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simplified rendering of the events of embryogenesis and include exogenous reagents used 
in the laboratory to guide these processes for the specific purpose of generative 
cardiovascular derivatives. For example, Activin A ligand does not have a defined role in 
mouse embryogenesis (Matzuk et al., 1995), but its signaling pathway is active during 
early gastrulation (Cheng et al., 2003). Thus, our rendering of cardiogenesis simply 
serves to both situate the myriad of cardiovascular progenitor cells used for therapies in a 
developmental context and highlight the potential of each stage to produce various 
cardiovascular derivatives. Although a thorough discussion of the topic of stem cell 
plasticity at each stage of development is beyond the scope of this dissertation, the 
importance of a sufficiently early developmental state in cardiac repair has been 
highlighted in clinical trials and case reports, as discussed below. 
 
Cardiovascular Progenitor Cell Uses in Regenerative Medicine 
The use of a cardiac progenitor that has direct cardiomyogenic potential, such as 
endogenous CPCs, during transplantation may facilitate regeneration. Current clinical 
trials involving cardiovascular progenitors to stimulate repair in damaged heart tissue are 
promising (Bolli, 2011; Makkar, 2012; Gerbin, 2015); however, they are stymied by a 
failure of cells to engraft into the host tissue and by the use of progenitor types that are 
restricted in potency (Hong, 2014). Therefore, identifying the molecular events that 
promote enhanced stemness and regenerative potential in CPCs will benefit stem cell-
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Figure 1. Molecular cardiogenesis is guided by spatiotemporally regulated 
morphogens and transcription factors 
Morphogens and extracellular contact-mediated inductive cues activate signaling pathways 
that induce mesoderm development, subsequent commitment to the cardiac lineage, and 
the ultimate development of definitive cardiovascular derivatives. These pathways have 
been manipulated in vitro to culture cardiomyocytes from induced pluripotent, embryonic, 
and cardiovascular progenitor cells. Although several markers have been identified, the 
precise temporal regulation of each of these markers remains largely unknown. 
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based cardiac repair. Additionally, the successful use of autologous CPC sources to 
regenerate heart tissue in a predominately adult population requires additional 
understanding of the differences between adult and neonatal CPCs. Our laboratory has 
previously documented differences in age-dependent expression of microRNAs related to 
MAPK signaling, cytoskeleton regulation, adherens junction expression, and focal 
adhesion maintenance (Fuentes, 2013). As will be discussed later, several of these 
processes are affected by spaceflight. Moreover, while the functional shortcomings of 
adult CPCs require further elucidation, they are not the only barrier to effective cardiac 
regeneration based upon autologous cell therapy. 
Identifying the appropriate progenitor type that can be used in transplantation is 
still the subject of debate that has immense implications for cardiovascular repair. 
Previous studies that employed hematopoietic stem cells (Murry, 2004; Balsam, 2004) 
and mesenchymal stem cells (MSCs; Dixon, 2009) raised concerns over the myogenic 
capacity of these cell types. Godier-Furnemont, et al. (2011) employed MSCs in one such 
study. While enhanced angiogenic potential was noted, the authors acknowledged that 
cardiomyogenic differentiation of MSCs was unlikely. Employing these progenitor types 
that are not closely related to cardiac derivatives have resulted in underwhelming clinical 
trials (Segers, 2008). Since cardiomyocyte proliferation is limited, it has been challenging 
to transplant myocytes and achieve tissue-like cell densities (Sreejit, 2013; Dubois, 2010; 
Beitnes, 2009). In addition to cell lineage, research into the developmental status of the 
stage has provided encouraging results both in large animal models and human cases. 
 Interestingly, recent evidence has emerged that a progenitor cell that represents an 
early cardiovascular progenitor may facilitate myocardial repair. In a study of repair  
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Table 2. Animal studies, case reports, and clinical trials of stem cell-based cardiovascular 
repair 
 
aNo control group included; bIn the context of cardiovascular development, signal-
regulatory protein alpha (SIRPα) is indicative of a cardiomyocyte population (Dubois, 
2011). 
 
 
Cell source Dev Stage Outcome 
(vs Control) 
Study 
KDR+/PDGFR+  
hESC-derived CPCs 
Early +28% FS 
(at 28 days) 
Rodent 
(Fernandes et al., 2015) 
SSEA-1+/MESP1+/Oct4+ 
hESC-derived CPCs 
Early -20% Scar Size 
(at 2 months) 
Non-Human Primate 
(Blin et al., 2010) 
SSEA-1+/Isl1+ 
hESC-derived CPCs 
Early +10% LVEF 
(at 3 months) 
Case Report in Human 
(Menasché et al., 2015) 
c-Kit+ cardiospheres Late  
Unchanged LVEF 
(at 1 year) 
+2% LVEF 
(at 6 months) 
Human: CADUCEUS 
(Malliaras et al., 2014) 
 
(Makkar et al., 2012) 
c-Kit+ Adult CPCs Late  
+13.7 ± 4.5% LVEFa 
(at 12 months) 
+7.6 ± 2.4% LVEFa 
(at 4 months) 
Human: SCIPIO 
(Chugh et al., 2012) 
 
(Bolli et al., 2011) 
MSCs Late  
+8% EFa  
(at 12 months) 
+5% EFa  
(at 6 months) 
Human: POSEIDON 
(Hare et al., 2017) 
 
(Hare et al., 2012) 
MSCs  Late  +8% EFa  
(at 12 months) 
Human: TRIDENT 
(Hare et al., 2017) 
c-Kit+ CPCs Late +4% FS 
+8% LVEF 
(at 35 days) 
Rodent 
(Tang et al., 2010) 
Nkx2-5+/SIRPα+b  
iPSC-derived CPCs 
Late +4% LVEF 
(at 4 weeks) 
Rodent 
(Ja et al., 2015) 
CD34low  
BMC-derived MSCs 
Late Unchanged LVEF/EF 
(at 30 days) 
Human: TAC-HFT 
(Heldman et al., 2014) 
CD34low/CD133low 
BMCs 
Late -3% LVEF 
(at 6 months) 
Human: LateTIME 
(Traverse et al., 2011) 
BMCs Late Unchanged Measures Human: FOCUS-CCTRN  
(Perin et al., 2012) 
 11 
following myocardial infarction in nun-human primates, Blin et al. (2010) studied the 
efficacy of an early-stage cardiovascular progenitor that expressed stage-specific 
embryonic antigen 1 (SSEA-1), mesoderm posterior 1 (MESP1), and OCT4. The 
researchers observed differentiation of these early cells into ventricular cardiomyocytes, 
thereby healing approximately 20% of the scar tissue. The use of such a progenitor was 
demonstrated to be efficacious in a rodent model of myocardial repair (Bellamy, 2015).  
Meanwhile, Menasché et al. (2015) reported the first clinical case report of treatment 
using this early cardiovascular progenitor cell type. In brief, transplantation of SSEA-1- 
and Islet1-expressing CPCs derived from embryonic stem cells resulted in improved 
cardiovascular function. As shown in Table 2, studies of stem cell-based cardiovascular 
repair have revealed an emerging pattern in which an earlier cardiovascular progenitor 
more effectively improves cardiovascular function.  
Ultimately, increasingly strong evidence supports the use of progenitors that are 
only nascent in their commitment to the cardiovascular lineage in promoting 
cardiovascular repair. Moreover, recent evidence involving early CPCs that express 
Mesp1, SSEA-1, and Islet1 suggests that the developmental timing of cells used in such 
therapies is critical to the regeneration of cardiovascular function (Blin, 2010; Menasché, 
2015). Thus, research in cardiovascular regenerative medicine must also consider 
methods that enhance the regenerative potential of CPCs, possibly through the induction 
of an early developmental state. 
Efforts to identify and produce an earlier developmental state in stem cell 
populations have largely been studied in vitro. Yet, traditional cell culture conditions do 
not reflect the complex biomechanical processes of embryogenesis in utero. One major 
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difference between two-dimensional in vitro culture and the developing embryo is the 
presence of a buoyancy force generated by amniotic fluid that counteracts the effects of 
gravity (Andreazzol, 2017). One magnetic resonance imaging-based study estimated that, 
up until approximately the 21st week of gestation, the embryo and fetus develop in 
conditions that resemble neutral floating (Sekulic, 2005). Moreover, the human embryo 
does not undergo skin keratinization (i.e., body wall “hardening”) until after 
approximately gestational week 20 (Underwood, 2005), thus indicating that the buoyancy 
force generated by the amniotic fluid is transmitted to the fluid inside the embryo. Thus, 
to the extent that intracellular densities of embryonic cells are of the same density as the 
amniotic fluid (Valles, 2002), the embryo in utero experiences conditions of relative 
weightlessness, or reduced gravity. For this reason, researchers have turned their attention 
to recapitulating the physics of intrauterine development more closely. Research by the 
laboratory of Alan Flake has demonsrated that a biomimetic uterus can effectively 
facilitate proper development in extremely premature lamb (Partridge, 2017). Elsewhere, 
three-dimensional cultures and microgravity have been studied to understand how such 
conditions can promote stem cell development and function. 
 
Stem Cells and Reduced Gravity Conditions 
Humankind has long been interested in our expanded presence in space. Although 
only a handful of astronauts ever spend time in orbit, the technology that is developed by 
NASA for spaceflight has been broadly shared with society. Such advances have 
impacted many facets of human society on Earth, including transportation, public safety, 
health and medicine, and computer technology. With advances in the life science research 
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capacity of the National Lab aboard the International Space Station (Blaber, 2014), 
biologists have become empowered to similarly advance stem cell research for the benefit 
of society both in space and on Earth. In the context of cardiac stem cell therapies, as 
further discussed below, microgravity increasingly appears to represent one avenue by 
which a desirable stem cell population can be achieved. 
In reviewing the myriad studies regarding stem cells under simulated 
microgravity or aboard a space-bound vessel, several trends have emerged. First, stem 
cells exhibit reduced terminal derivative and enhanced self-renewal and stemness marker 
expression during exposure to reduced gravity conditions (Blaber, 2015; Fuentes, 2015). 
Second, upon return to normal gravity conditions, microgravity-exposed cells are more 
readily able to differentiate into neurons (Chen, 2011), bone nodules (Blaber, 2014), or 
cardiomyocytes (Jha, 2016). As researchers continue to explore the adaptation of stem 
cells to reduced gravity conditions, the prospect of engineering tissue using microgravity-
exposed progenitors has increased. However, a greater understanding of the mechanism 
by which stem cells adapt to reduced gravity conditions is needed in order to enjoy the 
benefits of microgravity-cultured stem cells in clinics on Earth. 
 
Mechanotransduction under Microgravity 
Across models and culture systems, molecular biologists have increasingly 
identified the role of small RhoGTPases in mediating the response of cells to a reduced 
gravity environment (Meyers, 2006; Louis, 2015). RhoA and CDC42 are small 
RhoGTPases that associate with the actin cytoskeleton (Cenni, 2003), participate in the 
non-canonical Wnt planar cell polarity pathway (Komiya, 2008), and modulate 
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intracellular calcium potentiation (Kim, 2009). Other experiments have identified 
alterations to small RhoGTPases, such as the suppression of RhoA in MSCs, in response 
to SMG (Seki, 2006). Elsewhere, researchers have reported the involvement of the 
primary cilium, which coordinates the early molecular events of cardiogenesis (Clement, 
2009), as a sensor of cell-cell contact and altered mechanical stress (Moorman, 2007). 
Interestingly, RhoA activity was found to be related to ciliogensis (Pan, 2007), further 
supporting the hypothesis that small RhoGTPases have an important role in cardiac 
development. 
Ultimately, this reduction in RHOA expression logically follows from the reduced 
mechanical stress that is expected under microgravity conditions. Furthermore, 
mechanotransduction-induced changes in RhoA expression would be expected to impact 
calcium handling. Indeed, substrate rigidity (or the lack thereof in this context), has been 
shown to directly impact calcium oscillations within MSCs. Using fluorescence 
resonance energy transfer, Kim et al. (2009) observed changes to Ca2+ oscillation in 
accordance with changes to the stiffness of the MSC culture environment. Similarly, we 
found that calcium pathway genes and those related to calcium handling were expressed 
at higher levels under SMG (Baio, 2018). Meanwhile, the modification of signaling 
pathways related to calcium, either as an important secondary or mediating molecule, 
directly impacts the ability of CPCs to differentiate or maintain pluripotency (Tonelli, 
2012; Apati, 2016). Such findings indicate that research into the molecular events 
underpinning the adaptation of stem cells to reduced gravity conditions will have 
implications for regenerative medicine here on Earth. 
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Potential Therapeutic Benefits of Reduced Gravity 
Research in our own laboratory has shown that simulated microgravity (SMG) 
impacts the developmental profile of human cardiovascular progenitor cells (Fuentes, 
2015). In particular, earlier cardiac developmental genes were induced in neonatal CPCs 
following exposure to SMG for 6-7 days. The observation that a sufficiently early, 
cardiac-committed progenitor exhibits enhanced efficacy upon transplantation in vivo 
(Bellamy, 2015; Blin, 2010; Menasché, 2015) prompts molecular biologists to further 
explore the potential therapeutic use of reduced gravity conditions in advancing stem cell 
therapies. Initial research into the mechanism governing these observations indicated that 
small RhoGTPases and Wnt signaling as being some of the systems affected by the 
simulated microgravity environment. Elsewhere, the effect of mechanical unloading on 
mouse embryonic stem cells (ESCs) has been shown to impact differentiation and 
stemness, with experiments by Blaber et al. (2015) demonstrating that embryoid bodies 
retain markers of self-renewal and exhibit reduced definitive germ layer marker 
expression when flown in space. However, in the same studies, when mechanically 
unloaded embryoid bodies returned to Earth, they were able to differentiate more readily 
into contractile cardiomyocyte colonies. Similarly, Jha et al. (Jha, 2016) found that 
human induced pluripotent stem cells more readily differentiate into cardiomyocytes 
using three-dimensional culture coupled with transient, early exposure to SMG. These 
separate experiments may represent a similar phenomenon in which a low gravity culture 
promotes an enhanced state of stemness under SMG or microgravity (MG) that results in 
increased differentiation ability when the cells are returned to normal gravity conditions. 
Thus, stem cell therapies relevant to cardiac repair may be improved by manipulating the 
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mechanisms relevant to mechanical signaling in cardiovascular progenitors. In particular, 
inducing enhanced stemness in cardiovascular progenitors may facilitate a 
correspondingly enhanced clinical effect upon transplantation. 
Alterations in mechanical sensing molecules, such as the small RhoGTPases, are 
believed to be involved in the molecular adaptation to microgravity (MG; Meyers, 2005; 
Louis, 2015). Importantly, these molecules are also able to impact intracellular signaling 
pathways, such as calcium oscillations, which subsequently can activate AKT (Gocher, 
2014) and extracellular-signal regulated kinase (ERK; Schonwasser, 1998). In the context 
of cardiogenesis, these processes are critical to maintaining a balance between inductive 
and proliferative cues (Romorini, 2016; Pucéat, 2005). Therefore, manipulating the 
normal gravity environment of early CPCs may highlight important mechanisms by 
which early cardiac progenitors develop or expand. Such insights may be applied to 
further understand cardiovascular development and to enhance the outcomes of stem cell-
based regenerative therapies. Therefore, the application of findings from microgravity 
experiments to Earth-based experiments may help overcome the shortcomings of current 
clinical trials involving the use of CPCs for cardiac repair. 
 
Sinoatrial Nodal Induction under Reduced Gravity 
 Two lines of evidence support the application of reduced gravity-mediated 
signaling events to sinoatrial nodal development. First, the induction of an earlier 
developmental state logically supports the development of sinoatrial nodal cells, which 
are hypothesized to be myocardial cells maintained in an embryonic state (Bakker, 2010). 
Second, recent studies of CPCs in our laboratory (Baio, 2018) and a recent study of 
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neural crest progenitors (Hatzistergos, 2018) both demonstrated that simulated 
microgravity induced the expansion of mesoderm-derived pacemaker sinoatrial nodal 
cells.  
In considering the first line of evidence, several studies have shown that an early 
developmental state may provide, or simply constitute, the appropriate cell source for 
biological pacemaker development. In an avian model, Bressan et al. (2013) used fate 
mapping to determine that sinoatrial nodal cells were observed to already be specified 
shortly after gastrulation prior to the onset of cardiogenesis within a region that was 
observed to be Nkx2-5- and Isl1-negative. Meanwhile, the Keller group recently reported 
a method of generating sinoatrial nodal-like pacemaker cells in Nkx2-5-negative 
cardiomyocytes (Protze, 2017). In this way, both groups demonstrate that developmental 
timing is critical to the development of this pacing structure. Finally, studies of definitive 
sinoatrial nodal cells indicate that primitive myocardium features, such as a simple 
ultrastructure, small cell size, dearth of mitochondria, and low contractility, persist in the 
definitive structure (Bakker, 2010). 
Studies of stem cells under reduced gravity conditions both directly and indirectly 
hint at the developmental pathways that may be involved in sinoatrial nodal development. 
Indeed, as stated previously, pacemaker cell expansion under simulated microgravity has 
been observed directly by Hatzistergos et al. (2018) and indirectly in our laboratory 
(Baio, 2018). Furthermore, the observation by Bressan et al. (2013) that pacemaker cells 
are specified shortly after gastrulation and prior to the onset of cardiogenesis in a 
population of Nkx2-5- and Isl1-negative cells is mirrored by a similar reduction in 
Nkx2.5 and Isl1 expression in CPCs under SMG (Baio, 2018). Moreover, calcium 
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signaling, which has an integral role in the process of CPC adaptation to spaceflight 
(Baio, 2018), is activated in the developing cardiac conduction system through Wnt7a 
(Gessert, 2010), which mobilizes intracellular calcium (Thrasivoulou, 2013). Finally, a 
recently published study from the laboratory of Ann C. Foley that sought to clarify the 
mechanism underpinning SAN induction found that MAP3K7, or TGFß-activated kinase 
1, overexpression in mouse embryonic stem cells faithfully induced sinoatrial node 
development (Brown, 2017). Similarly, MAP3K7, is inducible via TGFß signaling, 
which was found to be induced in CPCs under SMG (Baio, 2018). As an important aside, 
MAP3K7 activation via TGFß signaling can induce cardiac hypertrophy when 
overexpressed in myocardium (Zhang, 2000), but apparently promotes sinoatrial nodal 
development when overexpressed in a sufficiently early progenitor cell. Thus, the 
application of simulated microgravity-inspired signaling to sinoatrial nodal cell 
development likely requires an appropriately early progenitor cell. 
When considered together, both lines of evidence support the emerging 
hypothesis that sinoatrial nodal cells represent a de-/un-differentiated state of cardiac 
development (Bakker, 2010). Thus, findings from the study of CPCs under reduced 
gravity conditions will serve as the basis for the induction of sinoatrial nodal cells on 
Earth. In this way, a foundational understanding of the molecular biology and physiology 
of SAN cells is central to several components of this dissertation. 
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Figure 2. Putative molecular embryology of the SAN (Christoffels, 2010) 
Using animal models over previous decades, several key transcriptional factors have 
been involved in the ultimate expression of the HCN family of genes. Yellow 
indicates mesenchymal precursor tissue while gray indicates sinus horn myocardium 
and dark blue indicates atrial myocardium. rvv: right venous valve; raw: right atrial 
wall.  
 
TropT; Cxn43    Hcn4; Cxn45 
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Sinoatrial Node Molecular Development 
While most cells that express Nkx2.5 eventually become heart tissue, not all heart 
cells are Nkx2.5-positive. Indeed, as discussed below, cells that are destined to become 
the sinoatrial node (Mommersteeg, 2007; Espinoza-Lewis, 2009) have been shown to be 
absent of Nkx2.5. Although the sinoatrial node is located at the inflow tract that is 
formed, in part, by the second heart field, it is molecularly unlike the other derivatives of 
this region of cardiogenic mesoderm. Therefore, whether the second heart field expresses 
Nkx2.5 is less significant than the observation that its inhibition in the putative tissue of 
the sinoatrial node allows for the expression of the sinoatrial node gene program. As 
shown in Figure 2, the Tbx5-mediated induction of Shox2 results in Nkx2.5 inhibition, 
thereby allowing for Hcn4 and Tbx3 expression and, ultimately, sinoatrial node 
formation (Munshi, 2012). Furthermore, Tbx3 then inhibits, through Shox mediation, 
atrial genes, such as Cx40 and Cx43, which encode for connexin proteins, as well as 
ANF, the atrial natriuretic factor that is involved in the homeostatic control of blood 
pressure through water and ion secretion regulation (Mommersteeg, 2007; Widmaier, 
2008; Boogerd, 2011). Paradoxically, Nkx2.5 expression can function synergistically 
with Tbx5 to promote the expression of Cx40 and Cx43 in other portions of the cardiac 
conduction system, such as the atrioventricular node (Munshi, 2012). The location of 
Shox2 expression participates in determining the mechanism of interaction between 
Nkx2.5 and Tbx5. In the inflow tract, Tbx5 regulates Shox2 expression, thereby allowing 
for Nkx2.5 inhibition and Bmp4 expression (Puskaric, 2010), which supports sinoatrial 
node development. Additionally, Isl1, a gene that is expressed ubiquitously in CPCs, 
including those of the second heart field (Bu, 2009; Cai, 2003), induces BMP expression, 
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thereby facilitating Tbx3 expression (Yang, 2006). The ultimately atria-apposed 
sinoatrial node may also make use of Isl1-expressing tissue of the second heart field-
derived right atrium to induce this BMP expression. Despite this relationship between the 
second heart field and the sinoatrial node gene Tbx3, it has been suggested that the avian 
sinoatrial node arises from a mass of mesoderm that is not located within, but rather 
posterior to, the second heart field (Bressan, 2013). This tertiary heart field utilizes Wnt 
signaling to specify pacemaking cells shortly after gastrulation. Since Wnt is observed to 
inhibit cardiac development (Bruneau, 2012), it is possible that the necessary inhibition 
of cardiac features, including gap junctions and atrial natriuretic factor production, for 
sinoatrial node development (Mommersteeg, 2007) occurs via a Wnt-mediated 
mechanism in addition to the evidenced role for Tbx3 in inhibiting atrial genes. 
Alternatively, Wnt suppression, as occurs in the outflow tract due to a gradient of Hopx 
expression that works with BMP through Smad proteins to suppress Wnt, promotes 
cardiomyocyte formation (Jain, 2015).  
Finally, the right-sided sinoatrial node is prevented from isomerizing (i.e., 
developing on the left) through the early expression of the Pitx2 homeobox gene 
(Mommersteeg, 2007). Briefly, Pitx2c positively regulates miR-106b expression, which 
directly represses sinoatrial node genes, including Shox2 and Tbx3 (Wang, 2014). 
For this reason, the sinoatrial node appears to develop in a manner that is 
molecularly distinct from other cardiac tissue. In fact, it is presently believed to develop 
from a unique population of heart tissue wherein Wnt expression prevails, thereby 
participating in the inhibition of the expression of otherwise default cardiac genes (e.g. 
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Nxk2.5). These unique, non-cardiac features must be considered while identifying 
precursor cells and developing an ex vivo sinoatrial node.  
 
Current Progress in Creating a Biological Pacemaker 
Presently, significant progress has been made concerning the isolation and 
characterization of endogenous CPCs (Bearzi, 2009; Davis, 2009; Fuentes, 2013; 
Menasché, 2015; Moretti, 2006). Nevertheless, no literature to date has reported the 
isolation of sinoatrial nodal cells without having first performed an induction technique 
using an exogenous agent or gene therapy. This may be due to the rarity of the relevant 
cells. Indeed, the sinoatrial node is only comprised of approximately 10,000 cells that are 
highly specialized to regulate the contraction of the approximately five billion 
cardiomyocytes of the human heart (Kapoor, 2013).  
In 2004, Rosen et al. issued a list of ideal characteristics of a biological 
pacemaker. Their work highlighted the need for the regenerated pacemaker to respond to 
autonomic regulation, thereby allowing for the heart to continuously couple cardiac 
output with a variable metabolic demand. Therefore, it is necessary to ensure that 
autonomic coupling pathways are preserved in the exogenously produced biological 
pacemaker.  
The in vivo transfer of genes has resulted in the successful generation of sinoatrial 
nodal cells. Tse et al. (2006) demonstrated the effectiveness of gene-based therapy for 
correcting automaticity generation and maintenance by transfecting a mutated form of 
HCN1, which favors channel opening into guinea pig hearts. Similarly, Potapova et al. 
(2004) transfected human mesenchymal stem cells with mHCN2 and injected these 
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transformed cells into the left ventricle of the canine heart, thereby producing left-sided, 
spontaneous automaticity. Recently, Tbx18 transduction in guinea pig cardiomyocytes 
resulted in the generation of sinoatrial nodal cells in vitro and in vivo (Kapoor, 2013).    
While these gene-based therapies have reliably produced intrinsic and automated 
biological pacemaker activity that has limited autonomic sensitivity, their potential 
contribution to neoplasia has not been documented. For this reason, the use of non-
transformed sinoatrial nodal cells may yield clinically-relevant therapies. For example, a 
recent study that cultured c-kit-positive mouse CPCs in angiotensin II-supplemented 
growth media reported the promotion of pacemaker-like cell differentiation (Xue, 2015). 
This study makes use of the presence of angiotensin-II receptors (ATRs) in the 
developing and adult heart (Hein, 2002). ATRs also are central mediators of cardiac 
tissue remodeling during heart failure (Tadevosyan, 2012). The angiotensin II receptor is 
a G-protein coupled receptor that is expressed throughout several types of tissues, 
including in the conduction system of the heart (Saito, 1987). Furthermore, these 
receptors are denser in the neonatal heart than in the healthy adult heart (Urata, 1989). 
The characterization of the angiotensin II receptors in rodent models has shown that its 
activation produces increases in ERK phosphorylation, nuclear [Ca++] levels, 
proliferation, and transcription (Tadevosyan, 2012). While the role of angiotensin-II and 
the ATR in SAN development have not been explored, several researchers have observed 
effects of angiotensin-II administration on cardiomyocyte electrical properties in rodents. 
These include decreases in gap junction conductance (De Mello, 1995, 1996) and 
alterations in the expression of connexin 43 (Severs, 1994). Moreover, intracellular 
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injection of angiotensin-II decreased the inward calcium current, which suggests the 
involvement of angiotensin-II in cardiac contractility (De Mello, 1998, 2004). 
Meanwhile, another study circumvented the need to induce or transfect cells by 
excising a porcine sinoatrial node and cultured the homogenized cells on a collagen-
based scaffold (Wan, 2009). While this study demonstrated the feasibility of utilizing a 
scaffold for ex vivo cell attachment, no molecular or physiological studies were 
conducted to confirm the persistence of functional sinoatrial nodes. 
These gene therapy-based and chemical cocktail induction strategies have been 
effective in furthering the understanding of the molecular significance of several families 
of genes in the sinoatrial nodal cell lineage, they are limited in their clinical suitability. 
Concerns over neoplasia or ectopic growths of tissue have prevented the wider 
application of cellular transformation in vivo; however, it has been observed that 
transgenic expression of the reprogramming cytokine TNF-α abolished any neoplastic 
growths (Behfar, 2007). Similarly, the absence of a relevant preclinical animal model 
(e.g. sheep or pig) presents a barrier for the eventual use of an exogenously produced 
sinoatrial node. Furthermore, effective transgenic induction of the growth of sinoatrial 
nodal cells still only transforms approximately 10%-20% of a progenitor population, 
while the remaining cells develop into cardiomyocytes. Whether these cells are truly 
pacemaking (i.e., sinoatrial nodal) cells or simply cardiomyocytes with sinoatrial-nodal 
like properties requires further characterization and functional testing (Barbuti, 2015). 
Recent work by the laboratories of Keller (Protze, 2017) and Foley (Brown, 2017) 
has produced important advances in the field of sinoatrial nodal development. Both 
laboratories treated embryonic (the Foley lab) or induced pluripotent (the Keller lab) stem 
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cells to induce cardiomyocytes that exhibit functional profiles characteristic of 
spontaneously depolarizing sinoatrial nodal cells. Whereas the former group 
overexpressed MAP3K7 to achieve this end (Brown, 2017), the latter group titrated 
Bmp4 treatment at the onset of cardiogenic mesoderm induction to create a sinoatrial 
nodal-like cell (Protze, 2017). Interestingly, working cardiomyocytes, which exhibit high 
contractility, exhibit a morphology that differs from that of sinoatrial nodal cells (Bakker, 
2010). However, the enriched population of SAN-like cardiomyocytes generated by 
Brown et al. (2017) and Protze et al. (2017) follows from observations in other labs that 
such cells can be produced in smaller percentages as a byproduct of inducing ventricular 
cardiomyocytes from ESCs using a standard protocol of temporally regulated 
moprhogens (Jha, 2016). Future work is needed to clarify whether such cells are 
functionally capable of serving as a biological pacemaker over a prolonged period of 
time, or whether they will revert into a ventricular- or atrial-like cardiomyocyte upon 
transplantation. Nevertheless, the use of human-derived CPCs as seeds for the 
development of an ex vivo sinoatrial node is possible. 
 
Preamble 
Spaceflight and simulated microgravity may promote the efficacious use of stem 
cells in therapies on Earth. Yet, in the context of cardiovascular progenitor cells (CPCs), 
the molecular events underpinning adaptation to microgravity remain unknown. The 
unique extracellular environment fostered by microgravity impacts key aspects of 
cardiogenesis, modifies early developmental gene expression, and induces expression of 
the sinoatrial nodal gene program. Therefore, in characterizing the molecular events by 
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which CPCs adapt to reduced gravity conditions, it is possible to identify key upstream 
elements that can be used to induce sinoatrial nodal gene expression and promote the 
development of a biological pacemaker.  
Thus, we first identified changes in CPC development and function following 
spaceflight as well as assessed its implications for CPC applications on Earth. In Chapter 
2, we characterize the developmental profile changes of CPCs following culture aboard 
the International Space Station. We present our findings regarding the key signaling 
components of the molecular events observed under microgravity and recapitulate 
portions of these key signaling events on Earth in Chapter 3. These findings are then 
extended in Chapter 4 to development of sinoatrial nodal cells. The physiology of treated 
cells, including pacing potential and responsiveness to autonomic regulation via 
treatment with epinephrine, was then assessed. 
In clarifying portions of the molecular events underpinning the response of 
cardiovascular progenitor cells to reduced gravity conditions, we identify novel avenues 
for advancing the use of stem cells in regenerative medicine, including biological 
pacemaker development, on Earth. 
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Abstract 
 The heart and its cellular components are profoundly altered by missions to space 
and injury on Earth. Further research, however, is needed to characterize and address the 
molecular substrates of such changes. For this reason, neonatal and adult human 
cardiovascular progenitor cells (CPC) were cultured aboard the International Space 
Station. Upon return to Earth, we measured changes in the expression of microRNAs and 
of genes related to mechanotransduction, cardiogenesis, cell cycling, DNA repair, and 
paracrine signaling. We additionally assessed endothelial tube formation, cell cycling, 
and migratory capacity of CPCs. Changes in microRNA expression were predicted to 
target extracellular matrix interactions and Hippo signaling in both neonatal and adult 
CPCs. Genes related to mechanotransduction (YAP1, RHOA) were downregulated, while 
the expression of cytoskeletal genes (VIM, NES, DES, LMNB2, LMNA), non-canonical 
Wnt ligands (WNT5A, WNT9A), and Wnt/calcium signaling molecules (PLCG1, PRKCA) 
was significantly elevated in neonatal CPCs. Increased mesendodermal gene expression 
along with decreased expression of mesodermal derivative markers (TNNT2, VWF, and 
RUNX2), reduced readiness to form endothelial tubes, and elevated expression of Bmp 
and Tbx genes, were observed in neonatal CPCs. Both neonatal and adult CPCs exhibited 
increased expression of DNA repair genes and paracrine factors, which was supported by 
enhanced migration. While microgravity affects cytoskeletal organization and migration 
in neonatal and adult CPCs, only neonatal CPCs experienced increased expression of 
early developmental markers and an enhanced proliferative potential. Efforts to 
recapitulate the effects of microgravity on Earth by regulating processes described herein 
may be a promising avenue for cardiac repair. 
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Introduction 
Changes to the cardiovascular system during spaceflight have prompted 
molecular biologists to understand the mechanisms of cellular adaptation to microgravity. 
As a result, researchers have begun to identify therapeutic benefits, such as enhanced 
stemness, following the application of microgravity (MG) and simulated microgravity 
(SMG) to a variety of stem cell types. Therefore, increased understanding of the response 
of cardiovascular progenitor cells (CPCs) to microgravity may not only benefit human 
health in space, but also provide insights into novel cardiovascular stem cell therapies 
that can be applied on Earth. 
Recent research in our own laboratory has shown that neonatal human CPCs 
cultured under SMG exhibit increased expression of markers of early cardiovascular 
development and pluripotency (i.e., MESP1, T (Brachyury), and POU5F1 (OCT4)) as 
well as broad changes to microRNA expression (Fuentes, 2015). The changes in 
microRNA expression experienced by CPCs under SMG mirrored the expression of 
similar microRNAs in human embryonic stem cells (ESC) under normal conditions of 
early cardiovascular development, thereby suggesting that SMG induces an epigenetic 
environment that favors an earlier development status. Such a state appears increasingly 
beneficial for cardiovascular repair. For example, the efficacy of multipotent stem cells 
expressing Isl1+ and SSEA-1+ in ameliorating the symptoms of severe heart failure was 
recently demonstrated in one patient (Menasché. 2015). Furthermore, KEGG analysis 
indicated that the microRNAs down-regulated in CPCs by SMG target several signaling 
pathways, such as MAPK and Wnt, which are relevant to well-characterized repair 
mechanisms or cardiac stem cell proliferation mechanisms in the heart. For example, 
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non-canonical Wnt ligands (i.e., Wnt2b, Wnt5a, and Wnt9a) have been shown to be 
associated with the injury response in neonatal rodent heart tissue (Mizutani, 2016). 
Therefore, our observations suggest that SMG may foster a developmental state and 
signaling events that could enhance the use of CPCs for cardiovascular repair. This is 
supported by one recent study by Jha et al. (2016), which demonstrated that human 
induced pluripotent stem cells more readily differentiate into cardiomyocytes following 
three-dimensional (i.e., embryoid) culture coupled with SMG. In the context of our 
findings, these experiments may highlight a potential phenomenon in which a low gravity 
culture promotes an enhanced state of stemness that results in increased differentiation 
potential when the cells are returned to normal gravity conditions.  
It is currently believed that small RhoGTPases act as transducers of the 
mechanical alterations that are observed under conditions of microgravity (Meyers, 2005; 
Louis, 2015). As actors in the planar cell polarity Wnt pathway, they have central roles in 
cytoskeletal remodeling. Along with the Hippo pathway and calcium signaling, small 
RhoGTPases represent one potential molecular substrate of gravity sensing. Notably, in 
the context of cardiogenesis, these processes are central to maintaining multipotency or 
directing differentiation (Pucéat, 2005). Despite the early reports of the effects of 
microgravity on stem cells, much is unknown about the mechanisms by which CPCs 
respond to a reduced gravity environment or how these cell types develop enhanced 
stemness. Hence, we are not yet able to leverage the therapeutic potential of altered 
gravity conditions here on Earth. While current clinical trials to stimulate repair in 
damaged heart tissue are promising (Bolli, 2011; Makkar, 2012; Gerbin, 2015), they are 
stymied by a failure of cells to engraft into the host tissue and by the use of progenitor 
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types that are restricted in potency (Hong, 2014). Therefore, identifying the molecular 
events that promote enhanced stemness and regenerative potential in CPCs under reduced 
gravity conditions will benefit stem cell-based cardiac repair. 
The successful use of autologous CPC sources to regenerate heart tissue in a 
predominately adult population requires additional understanding of the differences 
between adult and neonatal CPCs. Our laboratory has previously documented differences 
in age-dependent expression of microRNAs related to MAPK signaling, cytoskeleton 
regulation, adherens junction expression, and focal adhesion maintenance (Fuentes, 
2013). The relationship between these processes and the age-dependent response of CPCs 
to reduced gravity remain unknown, but they imply deficits in the intracellular 
transduction of environmental cues in the functional shortcomings of adult CPCs. 
Therefore, in this study, clonal lines of neonatal and adult human CPCs were 
cultured aboard the International Space Station (ISS). We sought to identify changes in 
these CPCs in response to the reduced gravity conditions that impact signaling, 
development, and stemness. We then characterized the divergent response of neonatal 
and adult CPCs to spaceflight. We present components of the adaptive cellular response 
to a reduced gravity environment and their implications for enhancing the regenerative 
potential of neonatal and adult CPCs. 
 
Materials and Methods 
Ethics Statement/Cell Isolation and Expansion 
CPCs were isolated from cardiac tissue of neonates (1 day – 1 month) or adults 
(57 – 72 years), as previously described (Fuentes, 2013). The Institutional Review Board 
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of Loma Linda University approved the protocol for use of tissue that was discarded 
during cardiovascular surgery, without identifiable private information, for this study 
with a waiver of informed consent. Briefly, atrial tissue was cut into small clumps 
(approximately 1.0 mm3) then enzymatically digested using collagenase (Roche, 
Indianapolis, IN) at a working concentration of 1.0 mg/mL. The resulting solution was 
then passed through a 40-µm cell strainer. Cells were cloned in a 96-well plate by 
limiting dilution to a final concentration of 0.8 cells per well to create populations for 
expansion. Cells were then screened for the co-expression of Isl1 and c-Kit. Clonal CPC 
cultures were selected for other markers of early cardiac development (KDR and 
PDGFRA) and then maintained using growth media comprised of 10% fetal bovine 
serum (Thermo Scientific, Waltham, MA), 100 µg/mL penicillin-streptomycin (Life 
Technologies, Carlsbad, CA), 1.0% minimum essential medium non-essential amino 
acids solution (Life Technologies, Carlsbad, CA), and 22% endothelial cell growth media 
(Lonza, Basel, Switzerland) in Medium 199 (Life Technologies, Carlsbad, CA). 
Mycoplasma contamination was tested using the MycoAlert Mycoplasma Detection Kit 
(Lonza, Basel, Switzerland) following the manufacturer’s protocol.  
 
Developmental Marker Detection Using Flow Cytometry 
Progenitor cell populations were fluorescently labeled with antibodies, as 
recommended by their respective manufacturers, and then analyzed using a 
MACSQuant® analyzer (Miltenyi Biotec, Auburn, CA). Briefly, for developmental 
marker detection, CPCs were incubated with Viobility 405/520 before being washed in 
1X PBS (Life Technologies, Grand Island, NY) containing 0.5% BSA (Research 
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Products International Corp, Mt. Prospect, IL) and 2mM EDTA (Sigma Aldrich, St. 
Louis, MO). Then, CPCs were stained for cardiac-related stem cell surface markers 
(PDGFRα, CXCR4, c-Kit, and SSEA1). CPCs were then fixed in 4% PFA (Sigma 
Aldrich, St. Louis, MO), permeabilized in 0.1% Tween-20 (Sigma Aldrich, St. Louis, 
MO), blocked in 0.6 M glycine (Sigma Aldrich, St. Louis, MO) solution containing 10% 
BSA (Research Products International Corp, Mt. Prospect, IL), and stained for 
intracellular, cardiac-related stem cell surface markers (Isl1 and Mesp1). For directed 
differentiation assays, cells were stained for TropT after being fixed in 4% PFA (Sigma 
Aldrich, St. Louis, MO), permeabilized in 0.1% Tween-20 (Sigma Aldrich, St. Louis, 
MO) or directly for vWF or SMA. Stained CPCs were then analyzed using a 
MACSQuant® analyzer (Miltenyi Biotec, Auburn, CA).  Quantification of data was 
performed using FlowJo software version 10 (Ashland, OR). Compensation was 
performed using UltraComp eBeads (Life Technologies, Grand Island, NY) following the 
manufacturer’s protocol. Briefly, one drop of compensation beads were incubated with 
each antibody individually for 30 minutes at 4ºC and then detected using the same 
MACSQuant® analyzer just prior to experiments requiring compensation. FlowJo was 
then used to generate a compensation matrix, which was applied to all experimental data. 
Information concerning antibodies, isotype controls, and reagents used in antibody 
labeling is provided in Table 3. 
 
Directed Differentiation of Cardiovascular Progenitor Cells 
To validate the ability of neonatal and adult CPCs to differentiate into cells of the 
cardiovascular lineage, directed differentiation assays were performed, as described in Le 
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et al. (2018) and Smits et al. (2009). In brief, to generate cardiomyocytes, CPCs were 
cultured in growth media (see above) until 85% confluent. CPC growth media was then 
replaced with differentiation media (47% IMDM, 47% Ham’s F12 with GlutaMAX, 
2.0% penicillin-streptomycin, 2.0% horse serum, 1.0% minimum essential medium non-
essential amino acids solution, and 1.0% insulin-transferring selenium (all reagents from 
Life Technologies, Carlsbad, CA) containing 5 µM 5-Azacytidine (Sigma, St. Louis, 
MO), which was refreshed daily for three days. Then, 1 ng/mL TGF-β (R&D Systems, 
Minneapolis, MN) and 0.1 mM ascorbic acid  (Acros Organics, Geel, Belgium) in fresh 
differentiation media was added routinely until day 14, at which time cells were stained 
for TropT or placed in TRIzol® reagent (Life Technologies, Carlsbad, CA) for gene 
expression analysis. To generate endothelium, CPCs were cultured in growth media (see 
above) until 85% confluent, at which time the growth media was replaced with 
endothelial cell growth media (Lonza, Basel, Switzerland) containing 25 ng/mL Bmp4 
(R&D Systems, Minneapolis, MN) and 50 ng/mL Vegf (R&D Systems, Minneapolis, 
MN) for two days. The media was then replaced with endothelial cell growth media 
(Lonza, Basel, Switzerland) containing 50 ng/mL Vegf and cultured for four days. Then, 
cells were regularly fed endothelial cell growth media (Lonza, Basel, Switzerland) until 
day 14, at which time cells were stained for vWF, placed in TRIzol® reagent (Life 
Technologies, Carlsbad, CA) for gene expression analysis, or seeded onto Matrigel for 
tube formation assay analysis, as described below. Finally, to generate smooth muscle 
cells, CPCs were cultured in growth media (see above) until 85% confluent, at which 
time the growth media was replaced with DMEM (Life Technologies, Carlsbad, CA) 
containing 4.5 g/L D-glucose, 2% fetal bovine serum (Thermo Scientific, Waltham, MA), 
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and 50 ng/mL PDGF-BB (R&D Systems, Minneapolis, MN). This media was regularly 
replaced until day 14, at which time cells were stained for smooth muscle actin or placed 
in TRIzol® reagent (Life Technologies, Carlsbad, CA) for gene expression analysis. 
Antibodies used for flow cytometry analysis are included in Table 4. 
 
Biocell Seeding and Spaceflight 
Neonatal and adult CPCs were seeded into Biocells (BioServe Space 
Technologies, Boulder, CO) at two seeding densities (7,500 cells or 5,000 cells) and 
loaded into self-contained environments containing 5% CO2 and 95% air. They were then 
flown aboard SpaceX CRS-11 to the US National Lab on the ISS where they were placed 
in an incubator containing 5% CO2 and 95% air. Fresh media was provided every four to 
five days while aboard the ISS (Figure 5). At 12 days, the Biocells that were seeded with 
7,500 cells were flooded with RNA Protect (Qiagen, Valencia, CA) and stored at -80ºC. 
At 30 days, the Biocells seeded with 5,000 cells were fed and returned to Earth. Clone- 
and passage-matched ground controls were fed and treated in parallel with the feeding 
schedule and activities performed by astronauts aboard the ISS. 
 
Post-Flight Sample Processing 
Upon landing and retrieval of the payload, live cells were trypsinized, counted, 
and used to assess cell cycle, migration, and endothelial tube formation, as well as to 
prepare protein lysates. Biocells containing cells fixed and frozen in RNA Protect were 
thawed at room temperature. The RNA Protect was removed and centrifuged at 10,000g 
at 4ºC for 10 minutes. Biocells were disassembled and the culture membranes were then 
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rinsed with TRIzol® reagent (Life Technologies, Carlsbad, CA). RNA was purified from 
the RNA protect samples using the RNeasy Mini Kit (Qiagen, Valencia, CA), per the 
manufacturer’s instructions, while total RNA was purified from TRIzol® reagent using 
isopropanol- and ethanol-based precipitation. cDNA was generated and RT-PCR was 
performed as described below. 
 
RT2 MicroRNA Profiler Array and miRNA RT-PCR 
MicroRNA array profiling was performed as previously described (Fuentes, 
2015). Briefly, the miScript II RT Kit (Qiagen, Valencia, CA) was used to convert 500 ng 
of total RNA into cDNA, which was diluted, added to miScript SYBR Green PCR master 
mix and 10X universal primer mix (Qiagen, Valencia, CA), and run on human 
development and differentiation miScript plates (MIHS-103ZA; Qiagen, Valencia, 
CA). Fold changes were determined for each clone using the Qiagen Data Analysis 
Center (http://www.qiagen.com/us/shop/ genes-and-pathways/data-analysis-center-
overview-page/) using all available housekeeping genes. Since this analysis center 
performs only a two-tailed Student’s t-test to calculate P-values, all fold changes for 
individual clones were exported to Prism and analyzed, as described below. Individual 
primers for SNORD96a, SNORD72, hsa-miR-100-5p, and hsa-miR-99a-5p 
(SABiosciences, Valencia CA) were also used (Table 5). The average Ct value of 
SNORD96a and SNORD72 was used as a housekeeping control. The PCR conditions for 
the microRNA arrays and individual microRNA assays were: 95°C for 15 minutes and 40 
cycles of 94°C for 15 seconds, 55°C for 60 seconds, and 70°C for 30  
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Antibody  Manufacturer Isotype Conc. Species Clone Cat. No. Lot No. 
Mesp1-DyLight 405 Novus Biologicals  IgG 0.8mg/mL Rabbit 2030B MAB921
9V 
CKNQ01-1-
050317-V 
Isotype-DyLight405 Novus Biologicals IgG 1.05mg/mL Rabbit NBP2-
36463V 
NBP2-
36463V 
31908-050317-
V 
Viobility 405/520  Miltenyi Biotec n/a n/a n/a n/a 130-109-
814 
5170315796 
Islet1 Abcam IgG1 0.83mg/mL Mouse 1H9 ab86472 GR273015-3 Fluorescein Labeling Kit Novus Biologicals n/a n/a 10934 707-0030 1BS3384 
Isotype-FITC BioLegend IgG1 
kappa 
0.5mg/mL Mouse MOPC-21 400107 B199152 
PDGFRα-PE BioLegend IgG1 
kappa 
100ug/mL Mouse 16A1 323505 B192368 
Isotype-PE BioLegend IgG1 
kappa 
200ug/mL Mouse MOPC-21 400113 B214532 
CXCR4-PE/Vio770 Miltenyi Biotec IgG1 82.5ug/mL n/a REA649 130-109-
887 
5170503056 
REA CtRl-PE/Vio770  Miltenyi Biotec IgG1 20ug/mL n/a REA293 130-104-
616 
5170201559 
cKit-DyLight650 Novus Biologicals IgG2B 
kappa 
500ug/mL Mouse 2B8 NB100-
77477C 
B147020-A 
Isotype-AlexaFluor 647 R&D Systems IgG2B 10ug/mL Rat 141945 IC013R AEIU0114121 
SSEA1-APC/Vio770 Miltenyi Biotec IgG1 8.25ug/mL n/a REA321 130-104-
992 
5161207356 
REA Ctrl-APC/Vio770 Miltenyi Biotec IgG1 30ug/mL n/a REA293 130-104-
618 
5170201560 
Table 3. Antibodies used to identify CPCs for experiments aboard the ISS 
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Antibody  Manufacturer Isotype Conc. Species Clone Cat. No. Lot No. 
TropT-PE Miltenyi 
Biotec 
IgG1 10 
µg/mL 
n/a REA4
00 
130-106-
746 
5160426814 
Isotype-PE BD Pharmigen IgG1 
kappa 
0.5 
mg/mL 
Mouse MOPC
-21 
556650 19587 
vWF-AlexaFluor 
657 
Novus 
Biologicals 
IgG1 
kappa 
0.75 
mg/mL 
Mouse 3E2D1
0 
NBP2-
34535AF6
47 
7450-
1PABX1605
19120816-
AF647 
Isotype-
AlexaFluor 647 
R&D Systems IgG2B 10 
µg/mL 
Rat 14194
5 
IC013R AEIU011412
1 
αSMA-PerCP Novus 
Biologicals 
IgG2a 
kappa 
0.4 
mg/mL 
Mouse 1A4/as
m1 
NBP2-
34522PCP 
59-
1PABX1706
19-090617-
PCP 
Isotype-PerCP Miltenyi 
Biotec 
IgG1 55 
µg/mL 
Mouse IS5-
21F5 
130-094-
968 
5110906188 
Table 4. Antibodies used in directed differentiation assays 
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Figure 3. ISS Experiment Schematic  
An outline of the experimental design for culture aboard the ISS, including how cell culture 
systems were prepared prior to launch and a timeline of experiments once aboard the ISS. 
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seconds. Differences in fold changes between ground- and ISS- cultured CPCs were then 
analyzed as described in the statistics sub-section. 
 
MicroRNA Targeting Prediction 
KEGG analysis was performed using DIANA mirPath version 3 and TarBase v7.0 
for microRNAs that were found to be significantly altered in neonatal and adult CPCs. 
Results were merged by pathway union after controlling for error rate due to multiple 
comparisons via selecting the “correct for FDR” feature. After removing categories 
related to cancer, neurological diseases, and viruses/pathogenesis, the KEGG categories 
whose p-values were less than 0.05 were reported. 
 
RT2 Profiler Array 
We used custom array plates (CLAH22469A; Qiagen, Valencia, CA) per the 
manufacturer’s instructions to measure gene expression changes in ISS-cultured adult and 
neonatal CPCs that were relevant to Wnt, ERK, BMP/Smad, and Notch signaling; 
cytoskeletal maintenance; calcium handling; apoptosis and cell cycle; cardiac 
development and stemness; and regeneration. Briefly, 2 µg of RNA was reverse 
transcribed into cDNA, as described above, and then thoroughly mixed with 2X RT2 
SYBR Green Mastermix and RNase- and DNase-free water before being loaded into the 
profiler array plate. Samples were amplified in the iCycler iQ™5 PCR Thermal Cycler 
(Bio-Rad, Hercules, CA) using a protocol of 95°C for 10 minutes and 40 cycles of 95°C 
for 15 seconds and 60°C for one minute. Fold changes were determined for each clone 
individually using the Qiagen Data Analysis Center (http://www.qiagen.com/  
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Table 5. Primer pair sequences used in RT-PCR experiments  
The catalog number, manufacturer, and name of microRNA primers that were not originally 
included in microarray plates as well as gene names and sequences (reported 5’ to 3’) 
included in experiments. 
Gene Forward Sequence (5’ to 3’) Reverse Sequence (5’ to 3’) 
ACTA2 AGCTTTCAGCTTCCCTGAACA TACAGAGCCCAGAGCCATTG 
ACTIN TTTGAATGATGAGCCTTCGTCCCC GTCTCAAGTCAGTGTACAGGTAAGC 
ATM GGGCGAGCCGCAAACGCTAA TTCGGCCCGTCGGAGCAAAC 
E2F1 GACCATCAGTACCTGGCCGAGAG GACGACACCGTCAGCCGAGTG 
HGF CACGAACACAGCTTTTTGCC TGATCCCAGCGCTGACAAAT 
HMOX1 CTCTCGAGCGTCCTCA ACTATCAGACAATGTTGT 
HSP70 TGACCAAGATGAAGGAGATCG GTCAAAGATGAGCACGTTGC 
IGF1 CAGAGCAGATAGAGCCTGCG CAGGTAACTCGTGCAGAGCA 
MESP1 TAGGCCTCAGCGAGGAGAGT TCCCTTGTCACTTGGGCTCC 
MLC2V GGTGCTGAAGGCTGATTACGTT TATTGGAACATGGCCTCTGGAT 
MYH11 CAAATACGCGGATGAGAGGGA CTCATGGACGTTCTTGCCCA 
NKX2-5 CGCCGCTCCAGTTCATAG GGTGGAGCTGGAGAAGACAGA 
PECAM1 AACGGAAGGCTCCCTTGATG TAAGAACCGGCAGCTTAGCC 
POU5F1 AACCTGGAGTTTGTGCCAGGGTTT TGAACTTCACCTTCCCTCCAACCA 
RAD23A GTATCGGAGCAGCCGGCCAC TCCCCAGGGGGCTCGTTCAG 
RAD50 CTACGGCTTTGCGTCCCCGG ACACCAGCTTTCCCCGC 
SDF1A CTACAGATGCCCATGCCGAT GTGGGTCTAGCGGAAAGTCC 
SOX2 AACCAGCGCATGGACAGTTA GACTTGACCACCGAACCCAT 
TERT AGAGTGTCTGGAGCAAGTTGC CGTAGTCCATGTTCACAATCG 
TNNT2 GTGGGAAGAGGCAGACTGAG ATAGATGCTCTGCCACAGC 
TP53INP1 CACAACAACAAAAGGACTTGGACT TTGAGCTTCCACTCTGGGAC 
TXNIP TCAGTATTGCAGGGCTTGGC GTCTCTTGAGTTGGCTGGCT 
VEGFA CAGCGAAAGCGACAGGGGCA GCTGGAGCACTGTCTGCGCA 
VWF ACACCTGCATTTGCCGAAAC ATGCGGAGGTCACCTTTCAG 
YAP1 TCCCAGATGAACGTCACAGC TCATGGCAAAACGAGGGTCA 
 
Symbol MicroRNA 
Catalog 
Number Manufacturer 
hsa-miR-99a-5p Hs_miR-99a_2 MS00032158 Qiagen 
hsa-miR-100-5p Hs_miR-100 Ms00031234 Qiagen 
SNORD72 Hs_SNORD72_11 MS00033719 Qiagen 
SNORD96A Hs_SNORD96A_11 MS00033733 Qiagen 
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us/shop/genes-and-pathways/data-analysis-center-overview-page/) using GAPDH and 
ACTB (β-actin) as housekeeping genes. Since this analysis center performs only a two-  
tailed Student’s t-test to calculate P-values, all fold changes for individual clones were 
exported to Prism and analyzed, as described below.  
 
Quantitative RT-PCR 
Changes in the expression of select genes were analyzed using RT-PCR. RNA 
was isolated from CPCs as described above. cDNA was prepared using 2 µg of RNA 
with Superscript III (Life Technologies, Carlsbad, CA). Quantitative real-time 
polymerase chain reaction (qRT-PCR) was performed using Go-Taq® qPCR Mastermix 
(Promega, Madison, WI) and the iCycler iQ™5 PCR Thermal Cycler (Bio-Rad, 
Hercules, CA) following a protocol of 94°C for 10 minutes and 45 cycles of 94°C for 15 
seconds, 52–68°C (depending on the primer) for 60 seconds, and 72°C for 30 seconds. 
RT-PCR products were visualized using 1–2% agarose gel electrophoresis and low mass 
DNA ladder (Invitrogen, Carlsbad, CA). Primers were designed using the National 
Center for Biotechnology Information Primer-BLAST program and obtained from 
Integrated DNA Technologies (Coralville, IA). Primers used in experiments are listed in 
Table 5. 
 
Endothelial Tube Formation Assay 
Matrigel (Trevigen, Gaithersburg, MD) was added to a 96-well plate (50μL/well) 
and hardened in a humidified, 5% CO2 incubator at 37ºC for 1 hour. Cells (20,000/well) 
were then incubated for seven hours in EGM-2 media (Lonza Allendale, NJ) before being 
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stained with Calcein AM (Fisher Scientific, Pittsburg, PA) for 30 minutes. Their ability to 
form capillary-like networks was measured using an EVOS imaging system 
(ThermoFisher Scientific, Waltham, MA) and quantified with ImageJ (v1.47f, NIH, 
Bethesda, MD). 
 
Cell Cycle Analysis 
Aliquots of 250,000 cells were fixed with 70% ethanol overnight, incubated for 
60 minutes with RNAse A (Fisher Scientific, Pittsburg, PA), and stained with propidium 
iodide, prior to running samples on a MACSquant analyzer (Miltenyi Biotec, Auburn, 
CA) and analyzing cell cycle progression using the Dean-Jett-Fox model in the cell cycle 
analysis tool of FlowJo software (Ashland, OR). 
 
Migration Assay 
CPCs were trypsinized, counted, and resuspended in starving medium that 
contained IMDM with GlutaMAX (ThermoFisher Scientific, Waltham, MA), 1% Insulin-
Transferrin-Selenium (Life Technologies, Carlsbad, CA), and 0.5% FBS (Thermo 
Scientific, Waltham, MA). 50,000 CPCs were plated in the top chamber of a 96-well 
transwell migration assay (Corning, Union City, CA) with 8 micron pores. Standard CPC 
growth medium supplemented with 100ng/mL of SDF-1α (Life Technologies, Grand 
Island, NY) was used in the bottom chamber as a chemoattractant. After 6 hours, 
migrated cells in the bottom chamber were stained using Calcein AM (Fisher Scientific 
Pittsburg, PA) and quantified using a FLX800 fluorescent plate reader (Bio-Tek, 
Winooski, VT). 
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Statistical Analysis 
The Shapiro-Wilk test for normality was used to test the normality of data 
distribution. We then performed a two-tailed, paired t-test to compare the mean of all 
normally distributed data. Non-normally distributed data were compared using a 
Wilcoxon matched-pairs signed rank text. For cell cycle, migration, and endothelial tube 
formation assay, samples in each group were pooled and either a two-tailed, unpaired t-
test or Mann-Whitney U test was used to compare the mean of normally or non-normally 
distributed data, respectively. All data are reported as the mean ± the standard error of the 
mean. Prism 7 version 7.02 (GraphPad, La Jolla, CA) was used for all statistical analyses. 
P values < 0.05 were assumed to indicate statistical significance.  
 
Results 
CPCs Exhibit Markers of Early Mesodermal Development 
CPCs were clonally isolated, expanded, screened for the co-expression of Isl1 and 
c-Kit, assessed for viability, and ultimately selected for experiments based upon the 
expression of early developmental markers (Mesp1, PDGFRα, and SSEA1) along with 
the chemokine receptor CXCR4. Representative adult and neonatal clones are shown in 
Figure 4. Clonal lines of CPCs obtained from neonatal and adult patients were then flown 
aboard the ISS for 12 days and fixed in RNAprotect during orbit (Figure 3). 
  
 54 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4. CPCs express markers of early mesodermal development 
Neonatal (blue) and adult (red) CPC clones were screened for the co-expression of Isl1 and 
c-Kit, assessed for viability, and then ultimately selected for experiments based upon the 
co-expression of early developmental markers (Mesp1, PDGFRα, KDR, and SSEA1) along 
with the chemokine receptor CXCR4. 
 
 
 
Isl1
 
PD
GF
Rα
 
CX
CR
4 
c-K
it 
Mesp1 Isl1 PDGFRα CXCR4 c-Kit SSEA1
Isl1
 
PD
GF
Rα
 
CX
CR
4 
c-K
it 
SS
EA
1
Me
sp
1 
Neonatal CPC                Adult CPC                 Unstained 
 55 
CPCs Differentiate Into All Three Major Cardiovascular Lineages 
To validate the identity of neonatal and adult CPCs, cells expressing markers of 
early mesoderm were treated with directed differentiation protocols for two weeks before 
being assessed for relvant gene and protein expression using RT-PCR and flow 
cytometry, respectively (Figure 5A). CPCs were treated with 5-azacytidine and Tgfβ to 
induce cardiomyocytes, which subsequently expressed elevated levels of cardiomyocyte 
markers TNNT2, MLC2V, and the protein TropT (Figure 5B-C). Separately, CPCs were 
treated with Vegfa, Bmp4, and endothelial growth media to induce endothelial cells, 
which subsequently expressed elevated levels of endothelial markers VWF, PECAM1, 
and the protein vWF (Figure 5D-E). Endothelial tubes were then formed from endothelial 
cells (Figure 5F). Finally, cells were treated with Pdgf-BB in DMEM containing 4.5 g/L 
glucose to induce smooth muscle cells, which subsequently expressed elevated levels of 
smooth muscle cell markers ACTA2, MYH11, and the protein αSMA (Figure 5G-H).  
 
Microgravity Mediates Changes to Expression of microRNAs That Target Membrane 
Synthesis and Extracellular Interactions 
In an effort to understand the relevant signaling events of a reduced gravity 
environment, we performed microarray analysis to measure broad alterations to 
transcriptional control. Of the 88 microRNAs analyzed, 14 exhibited significant 
alterations in levels of expression among neonatal and adult CPCs (n=3 unique clones per 
age per group for all miRs, except miR-99a and miR100, which were measured in 
biological and technical triplicates, Figure 6). KEGG analysis by age group (Table 6)  
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Figure 5. Neonatal and adult CPCs can differentiate into all major cardiovascular 
lineages 
To validate the identity of CPCs used in experiments, directed differentiation protocols 
were used for cardiomyocyte, endothelial, and smooth muscle pathway induction (A). 
Cardiomyocyte (B-C), endothelial cell (D-E), endothelial tube (F), and smooth muscle cell 
(G-H) induction was screened after 14 days by RT-PCR and flow cytometry. Gene 
expression patterns for the mesodermal marker MESP1 and differentiation markers were 
measured in each unique differentiation experiment. n=3–9 replicates. Data: mean ± SEM, 
*p<0.05, **p<0.01, ***p<0.001. 
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Figure 6. Microgravity alters microRNA expression in neonatal and adult early CPCs 
Neonatal and adult CPCs both exhibited significant alterations in microRNA expression 
following 12 days of culture aboard the ISS. KEGG analysis (Table 6) indicated likely 
targeting of ECM interactions, membrane metabolism, and Hippo signaling by these 
microRNAs. n=3–9. Data: mean ± SEM, *p<0.05, **p<0.01, ***p<0.001. 
 
 
 
Neonatal Ground 
Neonatal ISS 
Adult Ground 
Adult ISS 
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Table 6. KEGG analysis of targets of significantly altered microRNAs  
Following spaceflight, neonatal and adult CPCs were screened for changes to microRNA 
expression, which were then assessed using KEGG pathway analysis.  
 
Neonatal CPC KEGG Analysis Results 
KEGG pathway P-Value Genes miRNAs 
Fatty acid biosynthesis 0 2 1 
ECM-receptor interaction 0 14 2 
Hippo signaling pathway 1.94E-13 43 3 
Cell cycle 1.56E-05 43 3 
Lysine degradation 2.80E-05 16 2 
Glycosphingolipid biosynthesis - lacto and 
neolacto series 0.000139519 2 2 
p53 signaling pathway 0.002223088 25 3 
Protein processing in endoplasmic reticulum 0.02048608 51 2 
Endocytosis 0.02304169 52 2 
Thyroid hormone signaling pathway 0.04192693 34 2 
 
Adult CPC KEGG Analysis Results 
KEGG pathway P-Value Genes miRNAs 
Fatty acid biosynthesis 0 4 2 
ECM-receptor interaction 0 19 4 
Hippo signaling pathway 0 87 8 
Lysine degradation 1.11E-16 28 6 
Adherens junction 1.26E-10 51 5 
Cell cycle 2.97E-09 72 3 
TGF-beta signaling pathway 3.00E-08 49 5 
Protein processing in endoplasmic reticulum 4.16E-08 99 4 
Fatty acid metabolism 3.36E-06 16 2 
p53 signaling pathway 2.40E-05 41 4 
Endocytosis 0.000157412 76 3 
FoxO signaling pathway 0.000502794 51 3 
RNA transport 0.0013397 73 2 
Thyroid hormone signaling pathway 0.003808595 48 3 
Estrogen signaling pathway 0.003832405 29 3 
Ubiquitin mediated proteolysis 0.00920295 70 3 
Signaling pathways regulating pluripotency of 
stem cells 0.009475487 56 3 
Glycosaminoglycan biosynthesis - chondroitin 
sulfate / dermatan sulfate 0.01175345 9 2 
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indicated that fatty acid biosynthesis, extracellular matrix (ECM)-receptor interactions, 
and Hippo signaling were the most significantly affected targets of these microRNAs.  
 
Cytoskeletal Maintenance Is Altered in Neonatal, 
 But Not Adult, CPCs Under Microgravity 
Since the pathways targeted by the significantly dysregulated microRNAs affect 
cytoskeletal remodeling and mechanotransduction pathways (Figure 7A), we sought to 
measure changes in the expression of YAP1, a gene that encodes a critical Hippo 
signaling molecule; small RhoGTPases; and cytoskeletal molecules. YAP1 was 
significantly down-regulated in neonatal CPCs (fold change: 0.243 ± 0.833, n=3 unique 
clones each measured in triplicate per group, P=0.004; Figure 7B) and modestly 
upregulated in adult CPCs (fold change: 2.629 ± 0.186, n=2 unique clones each measured 
in triplicate per group, P=0.006; Figure 8A). Among small RhoGTPases, only RhoA was 
significantly downregulated in neonatal CPCs (fold change: 0.152 ± 0.087, n=3 unique 
clones per group, P=0.010; Figure 7C), while the cytoskeletal genes VIM, NES, DES, 
LMNB2, and LMNA were all significantly upregulated (fold changes: 5.180 ± 1.227, 
P=0.031; 21.460 ± 5.729; P=0.023; 6.005 ± 1.447, P=0.026; 5.096 ± 1.163, P=0.024; 
10.420 ± 2.930, P=0.033; respectively; n=3 unique clones per group) following 
spaceflight (Figure 7D). Meanwhile, in adult CPCs, only NES expression decreased 
significantly (fold-change: 0.279 ± 0.137, n=3 unique clones per group, P=0.006) (Figure 
8B & C). 
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Figure 7. Microgravity impacts expression of genes involved in mechanotransduction 
and cytoskeleton maintenance in neonatal CPCs  
Integrin and mechanical signaling impact Hippo activity and small RhoGTPases, which 
function along the Wnt planar cell polarity pathway (A). YAP1 expression was significantly 
reduced in neonatal CPCs (B). RHOA, a small RhoGTPase, was expressed at significantly 
lower levels (C) CPCs. Accordingly, cytoskeletal gene expression was significantly 
upregulated (E). Data are reported as the mean ± SEM, n=3–6 per group, *p<0.05, 
**p<0.01. 
A B 
C              D 
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Figure 8. Microgravity generally does not impact the expression of genes involved in 
mechanotransduction and cytoskeleton maintenance in adult CPCs  
YAP1 expression was significantly upregulated in adult CPCs (A). Small RhoGTPase 
gene (B) and cytoskeletal gene (C) expression was not significantly modulated by 
spaceflight. Data are reported as the mean ± SEM, n=3 per group, **p<0.01. 
  
A                  B             
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Microgravity Enhances Non-Canonical/Ca2+  
Signaling Gene Expression in Neonatal CPCs 
Given the role of small RhoGTPases in non-canonical, planar cell polarity Wnt 
signaling, we sought to assess the expression of genes involved in the calcium and 
canonical Wnt pathways. (Figs 9-10). In doing so, we observed significantly increased 
expression of GSK3B (fold-change: 6.798 ± 1.133, n=3 unique clones per group, 
P=0.036) in neonatal CPCs (Figure 9A) and significantly increased expression of 
CTNNB1 (fold-change: 1.891 ± 0.121, n=3 unique clones per group, P=0.018) in adult 
CPCs (Figure 10A). Since Gsk3β sequesters β-catenin for degradation in the cytoplasm, 
thereby suggesting suppression of canonical Wnt signaling in neonatal CPCs and the 
promotion of canonical Wnt signaling in adult CPCs, we measured non-canonical Wnt 
ligand expression and that of genes in the Wnt/Ca2+ pathway. We measured significantly 
increased WNT5A and WNT9A expression (fold changes: 36.440 ± 8.258, P=0.050; 
17.110 ± 3.411; P=0.042, respectively; n=3 unique clones per group) in neonatal CPCs 
(Figure 9B) and significantly decreased WNT9A expression (fold-change: 0.393 ± 0.170, 
n=3 unique clones per group, P=0.023) in adult CPCs (Figure 10B). This was supported 
by significantly increased expression of PLCG1 and PRKCA (fold changes: 14.110 ± 
1.468, P=0.012; 11.520 ± 2.974, P=0.0241; respectively; n=3 unique clones per group) 
and a general increase in ITPR1 expression (fold changes: 2.668 ± 0.623, P=0.055; 
10.240 ± 4.393; P=0.1034, respectively; n=3 unique clones per group) in neonatal (Figure 
9C), but not adult (Figure 10C), CPCs.  
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Figure 9. Genes involved in the non-canonical Wnt/Ca2+ pathway are expressed at 
higher levels in neonatal CPCs 
Canonical Wnt signaling genes were measured in neonatal (A) CPCs along with non-
canonical Wnt ligands (B). Genes involved in the non-canonical Wnt/calcium pathway 
were elevated in neonatal (C) CPCs. Data are reported as the mean ± SEM, n=3 per group, 
*p<0.05. 
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Figure 10. Genes involved in the non-canonical Wnt/Ca2+ pathway are not expressed 
at higher levels in adult CPCs 
Canonical Wnt signaling genes were measured in adult (A) CPCs along with non-canonical 
Wnt ligands (B). Genes involved in the non-canonical Wnt/calcium pathway were 
unchanged in adult (C) CPCs. Data are reported as the mean ± SEM, n=3 per group, 
*p<0.05. 
 
A                                     B    
 
 
 
 
 
 
 
 
 
 
 
 
 
                  C               
 
 66 
Neonatal CPCs Exhibit Increased Expression of Genes  
Involved in Pre-Mesodermal Development 
Calcium and Wnt signaling have central roles in cardiogenesis. For this reason, 
we sought to assess the transcription of markers of various stages of cardiac development. 
We observed that the expression of genes involved in embryonic stem cell self-renewal 
(POU5F1, NANOG, SOX2), mesodermal specification (FOXC1, MESP1, T), and early 
cardiogenesis (GATA4, KIT, PDGFRA, ISL1, KDR) increased, while NKX2-5 expression 
decreased, in neonatal CPCs (n=3 unique clones per group, Figure 11). In this population, 
the expression of genes involved in early mesodermal specification were the most 
significantly elevated. Conversely, adult CPCs generally exhibited decreased or 
unchanged expression of genes involved in early developmental processes, with the 
exception of PDGFRA (n=3 unique clones per group, Figure 11). Furthermore, increased 
telomerase activity, as indicated by enhanced TERT expression, was observed in neonatal 
CPCs following spaceflight (fold change: 6.782 ± 2.000, n=9 per group (three unique 
clones each measured in triplicate), P=0.020). Despite experiencing no change in 
expression in genes related to development, adult CPCs expressed higher levels of TERT 
expression (fold change: 21.150 ± 10.610, n=6 (three unique clones each measured in 
triplicate), P=0.007). 
 
Expression of BMP4 and TBXs 3, 5, and 18 Is  
Elevated Under Microgravity in Neonatal CPCs 
These modifications to the expression of genes involved in cardiogenesis 
motivated us to measure the changes in the expression of genes in the Bmp, Smad, and  
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Figure 11. Spaceflight induces early mesodermal gene expression in neonatal CPCs 
Markers of development were measured in neonatal and adult CPCs following 12 days of 
culture aboard the International Space Station. Gene expression analysis indicated that 
early mesodermal markers (i.e., FOXC1, MESP1, and T) were elevated in expression in 
neonates, but not in adults. Data are reported as the mean. *p<0.05. 
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Figure 12. Spaceflight modifies TBX, Smad, and BMP expression patterns 
The expression of members of the BMP, Smad, and TBX families of genes was measured 
after 12 days of culture aboard the ISS and was found to be elevated significantly in 
neonatal CPCs and modestly in adult CPCs. Data are reported as the mean. 
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Tbx families, which have important roles in pre- and early mesodermal development. We 
measured elevated expression of BMP4, TBX3, TBX5, and TBX18, and a general increase 
in BMP2 expression in neonatal CPCs (Figure 12). In adult CPCs, SMAD1 exhibited a 
significant increase in expression, while SMAD2 and TBX18 exhibited general increases 
in expression (Figure 12). 
 
Microgravity Reduces Endothelial Tube Formation and  
Terminal Mesodermal Derivative Marker Expression in Neonatal CPCs 
Given the elevated expression of early to pre-mesodermal genes in neonatal, but 
not adult, CPCs, we sought to measure whether MG enhances or reduces mesodermal 
derivative marker expression. Following 30 days in orbit, CPCs returned to Earth and 
were immediately assayed for endothelial tube formation capacity. Unlike adult CPCs, 
neonatal CPCs exhibited a significantly reduced ability to form tubes (n=3 measurements 
of four pooled clones per age per group, Figure 13). Representative images of tube 
formation of neonatal ground (Figure 13C) and ISS (Figure 13D) as well as adult ground 
(Figure 13E) and ISS (Figure 13F) samples reflect this age-dependent response of CPCs 
to spaceflight. Similarly, expression of the cardiomyocyte marker TNNT2, endothelial 
marker VWF, and osteoblast marker RUNX2 were all significantly reduced in neonatal, 
but not adult, CPCs after 12 days in orbit. Interestingly, sinoatrial nodal markers HCN4 
and SHOX2 exhibited elevated expression in neonatal CPCs and reduced expression in 
adult CPCs (n=3 unique clones per age per group, Figure 14). 
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Figure 13. Spaceflight reduces the propensity for neonatal CPCs to readily form 
endothelial tubes 
Following culture in biocells on the ground or the ISS for 30 days, CPCs were placed in 
endothelial growth media and incubated on Matrigel for 7 hours to facilitate endothelial 
tube formation. The area covered by the tubes that formed (A) and the number of branches 
(B) were quantified using ImageJ for neonatal ground (C) and ISS (D) CPCs as well as for 
adult ground (E) and ISS (F) CPCs (ruler = 1000µm). Data are reported as the mean ± 
SEM, n=3 measurements of four pooled clones, ***p<0.001. 
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Figure 14. Spaceflight reduces the propensity for neonatal CPCs to express markers 
of terminal mesodermal derivatives 
Changes in gene expression relevant to mesodermal derivatives were measured in CPCs 
cultured aboard the ISS for 12 days, indicating decreased expression of cardiomyocyte, 
endothelial, and osteogenic markers and increased expression of sinoatrial nodal markers. 
Data are reported as the mean ± SEM, ***p<0.001.  
 
 72 
ISS-Cultured Neonatal CPCs Proliferate More Rapidly  
Than Adult or Ground-Control CPCs 
To understand how these changes in early development marker expression affect 
proliferative potential, cell cycling was assessed using flow cytometry. The Dean-Jett-
Fox model was fitted to fluorescence intensity curves generated for propidium iodide-
stained neonatal and adult CPCs (n=3 measurements of four pooled clones per age per 
group; Figure 15A). Adult CPCs exhibited a significant decrease in the percentage of 
cells in the G1/G0 phase (ISS vs Ground: 70.9% vs 60.6%, p=0.003) and neonatal CPCs 
exhibited a significant increase in the percentage of cells in the G2/M phase (ISS vs 
Ground: 13.5% vs 17.17%, p=0.050; Figure 15B). Neonatal CPCs were more frequently 
in the G2/M phase both on the ground and following culture aboard the ISS. 
Interestingly, neonatal CPCs exhibited increases in CDKN2A (fold change: 14.080 ± 
2.604, n=3 unique clones per group, p=0.037), E2F1 (fold change: 9.012 ± 2.390, n=9 
(three unique clones each measured in triplicate), p=0.010), and PLK1 (8.509 ± 1.542, 
n=3 unique clones per group, p=0.040) (Figure 15C). These modulators of cell cycling 
were not significantly altered in adult CPCs (Figure 15D). Upon return to Earth, Biocells 
cultured aboard the ISS or on the ground contained 1,126,000 ± 176,000 or 152,300 ± 
46,700 neonatal CPCs. Meanwhile, Biocells seeded with adult pools that were cultured 
aboard the ISS or on the ground contained 407,300 ± 92,700 or 246,000 ± 26,000 adult 
CPCs, respectively (Figure 15E). As expected from cell cycle data, the cell counts after 
30 days in space were markedly larger in the neonatal CPC population (n=2 
measurements of four pooled clones per age per group). Viability of CPCs upon return to 
Earth after 30 days of culture was not adversely affected (Figure 15F). 
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Figure 15. Cell cycling and proliferation are enhanced following spaceflight in 
neonatal CPCs 
Following 30 days of culture aboard the ISS, CPCs were fixed, stained with propidium 
iodide, and measured using flow cytometry. The Dean-Jett-Fox model was then applied to 
the histogram of propidium iodide fluorescence intensity for ground- and ISS-cultured 
CPCs (A). Upon analysis (B), adult CPCs exhibited a significant decrease in the percentage 
of cells in the G1/G0 and neonatal CPCs exhibited a significant increase in the percentage 
of cells in the G2/M phase. This was supported by increased expression of CDKN2A, E2F1, 
and PLK1, which function to regulate G1/S arrest, overcome G1/S arrests, and promote 
G2/M progression, respectively, in neonatal (C), but not adult (D), CPCs. Despite enhanced 
proliferation (E), viability was not adversely affected (F). Data are reported as the mean ± 
SEM, n=3 measurements of four pooled clones per group for cell cycling analysis; n=3–9 
per group for all gene expression data, *p<0.05, **p<0.01, ***p<0.001.  
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DNA Repair Transcripts Increased Following Spaceflight 
The broad alterations experienced by CPCs and the possibility of exposure to 
radiation in the extraterrestrial environment prompted us to consider possible cellular 
stress response mechanisms, including the expression of DNA repair gene programs. We 
measured increased expression of genes involved in DNA repair, as indicated by elevated 
levels of ATM (fold change: 10.852 ± 3.446, n=9 (three unique clones each measured in 
triplicate), P=0.021), RAD23 (fold change: 7.943 ± 0.789, n=9 (three unique clones each 
measured in triplicate), P<0.001), and RAD50 (fold change: 21.250 ± 8.656, n=9 (three 
unique clones each measured in triplicate), P=0.033) (Figure 16A). Adult CPCs generally 
exhibited increased expression of DNA repair genes (Figure 16B); however, only ATM 
(fold change: 23.910 ± 0.682, n=9 (three unique clones each measured in triplicate), 
P=0.001) expression was significantly elevated.   
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Figure 16. DNA repair genes are induced by spaceflight in an age-independent 
manner. 
DNA repair gene expression was elevated, as indicated by increased levels of ATM, 
RAD23, and RAD50 expression (A). Adult CPCs generally exhibited increased DNA repair 
genes; however, only ATM expression was significantly increased (B).  Data are reported 
as the mean ± SEM, n=6–9 per group, *p<0.05, **p<0.01, ***p<0.001.  
 
 
 
 
 
 
 
 
A             Neonatal B             Adult 
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Stress Response, But Not Apoptosis, Genes Are Induced in CPCs 
Given the broad induction of transcripts associated with DNA repair, we sought to 
characterize the impact of other stressors that could influence cellular function during 
spaceflight. Neonatal CPCs exhibited a 25-fold increase (P<0.05) in NOTCH1 expression 
(Figure 17A-B), which confers protection as part of the adaptive cardiac stress response 
(Croquelois, 2008). In considering oxidative stress and that associated with spaceflight 
(Figure 17C-D; Cubano, 2001; Versari, 2013; Zupanska, 2013), we found that HSP70 
was elevated in both neonatal (12-fold, P<0.01) and adult (20-fold, P<0.05) CPCs, while 
TXNIP, TP53INP, and HMOX1 were all induced only in adult CPCs (21-fold, P<0.01; 
2.2-fold, P<0.05; 3.2-fold, P<0.001; respectively). Ultimately, neither adult not neonatal 
CPCs exhibited an induction of transcripts associated with the apoptosis pathway (Figure 
17E-F). As discussed previously, neither proliferation nor viability was reduced in either 
age group. 
 
Adult and Neonatal CPCs Both Exhibit a  
Greater Migratory Capacity after ISS Culture 
In addition to changes in the regulation of differentiation, cytoskeletal alterations 
were anticipated to occur in response to MG. For this reason, we measured the migratory 
capacity of ISS-cultured CPCs using a Transwell migration assay. Both neonatal and 
adult CPCs that were cultured aboard the ISS migrated at significantly higher levels in 
response to SDF-1α stimulation (Neonate (ISS vs Ground): 2963 ± 15 cells vs 1972 ± 69 
cells; n=5 measurements of four pooled clones per group; P=0.008; Adult (ISS v  
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Figure 17. CPCs exhibit minimal induction of genes involved in stress response 
pathways 
Given the harsh nature of the extraterrestrial environment, we sought to assess the impact 
of spaceflight on stress pathways. We measured changes in gene expression pertinent to 
the cardiac (neonatal, A; adult, B) and oxidative (neonatal, C; adult, D) stress response as 
well as apoptosis activation (neonatal, E; adult, F) in adult and neonatal CPCs flown aboard 
the ISS for 12 days. n=3 biological replicates. Data: mean ± SEM, *p<0.05, **p<0.01, 
***p<0.001. 
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Figure 18. CPCs have enhanced migratory capacity following spaceflight 
Both neonatal and adult CPCs that were cultured aboard the ISS migrated at significantly 
higher levels in response to SDF-1α stimulation (A). Similarly, SDF1A expression was 
elevated in both neonatal (B) and adult (C) CPCs following exposure to low Earth orbit. 
VEGFA expression was also significantly elevated in neonatal CPCs (B), while most other 
paracrine and growth factors generally increased regardless of age. Data are reported as the 
mean ± SEM, n=6–9 per group, **p<0.01, ***p<0.001.  
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Ground): 2247 ± 28 cells vs 1394 ± 52 cells; n=5 measurements of four pooled clones per 
group; P<0.001) (Figure 18A). Similarly, SDF1A transcripts were elevated in both 
neonatal (Figure 18B) and adult (Figure 18C) CPCs following exposure to low Earth 
orbit (Neonate: 31.950 ± 10.770-fold increase, n=9 (three unique clones each measured in 
triplicate), P=0.0039; Adult: 36.480 ± 16.150-fold increase, n=9 (three unique clones 
each measured in triplicate), P=0.0078). VEGFA transcripts were also significantly 
elevated in neonatal CPCs (15.78 ± 5.283-fold increase; n=9 (three unique clones each 
measured in triplicate); P=0.0068). 
 
Discussion 
In this study, we found that microgravity exerts broad effects on the 
developmental status, proliferative potential, and migratory ability of CPCs, some of 
which occurred in an age-dependent manner. In particular, neonatal CPCs exhibited 
increased expression of early developmental markers, enhanced proliferative potential, 
and increased migratory capacity under MG. Meanwhile, adult CPCs experienced little 
change in the expression of genes indicative of their developmental state, but exhibited 
changes to migratory capacity. These findings suggest that broad cytoskeletal 
modifications resulting from reduced mechanotransduction impart improved migratory 
and adhesion capabilities regardless of age, but that neonatal CPCs are able to propagate 
or experience additional intracellular signaling events (e.g., calcium signaling) that 
modify their developmental status. As we have shown elsewhere, one important 
difference between adult and neonatal CPCs is their epigenetic (i.e., microRNA) 
environment (Fuentes, 2013).  
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Several microRNAs were observed to be differentially regulated in response to 
spaceflight in neonatal and adult CPCs. Interestingly, the predicted targets of these 
microRNAs included activators and repressors of several pathways. A detailed inspection 
of the putative targets under each pathway impacted by the microRNAs identified in this 
study revealed the targeting of genes relating to Wnt signaling (FZD3, FZD5, FZD7, 
FZD8), cytoskeletal regulation (ACTB, ACTG1, LAMC3), cardiovascular development 
(TGFBR1, BMP2, BMP5, SMAD7), integrin function (ITGB4, ITGAV), extracellular 
proteins (COL4A2, COL5A1, COL1A1, COL1A2, COL4A1), and Hippo signaling 
(TEAD1, YAP1, LATS1). Interestingly, miR-16, whose expression was generally elevated 
in neonatal CPCs and repressed in adult CPCs, directly targets YAP1, which could 
account, at least in part, for the age-dependent response of CPCs to spaceflight. However, 
since KEGG analysis only identifies broad categories of genes (i.e., functional categories) 
that are likely targets of the microRNAs under study, further experiments are warranted 
to identify the cumulative impact of these microRNAs on signaling in space flown CPCs.  
 These results motivated us to assess the overall impact of spaceflight on YAP1, an 
effector of Hippo signaling that functions with TAZ to regulate transcription. Activation 
of Hippo kinases, such as through a loss of microRNA-mediated repression or through 
reduced mechanical signaling, results in elevated levels of phosphorylated Yap1 and Taz. 
This prevents translocation of these transcriptional activators to the nucleus. Similarly, 
the application of SMG to bone mesenchymal stem cells prevented TAZ translocation to 
the nucleus, thereby preventing the expression of RUNX2 and inhibiting osteogenesis 
(Chen, 2016). Similarly, the decreased expression of YAP1 and RUNX2 observed in this 
experiment indicate that spaceflight reduces mechanotransduction in neonatal CPCs. 
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In addition to broadly targeting the Hippo signaling pathway and ECM 
interactions, select microRNAs that were modified by MG are known to be critically 
involved in cardiac development. For example, miR-142-3p is involved in targeting 
genes involved in early cardiac development, such as TBX5 (Chen, 2017). Meanwhile, 
miR-302, which targets the type II BMP receptor to regulate early cardiogenic events, is 
repressed by Bmp4 in a Smad-dependent manner (Kang, 2012). Interestingly, we 
observed both generally reduced expression of miR-302c and a generally elevated 
expression of BMP4 in CPCs exposed to MG. Moreover, studies have demonstrated a 
direct mechanistic role of certain microRNAs in cardiac regeneration. As neonatal mice 
age, their cardiomyocytes lose their proliferative potential in a manner that is 
concomitant with increased let-7 family expression (Porrello, 2011), thereby indicating a 
relationship between let-7 over-expression and reduced proliferative potential. Indeed, 
let-7c along with miR-99/100, which were significantly down-regulated in neonatal 
CPCs, are also critically down-regulated during cardiomyocyte proliferation in a 
zebrafish model after ventricle amputation (Aguirre, 2014). As part of the amputation 
injury response, zebrafish cardiomyocytes near the site of injury undergo sarcomeric 
structure disassembly as a form of limited de-differentiation to prepare myocytes for self-
renewal. PLK1, which was upregulated in CPCs cultured aboard the ISS, is involved in 
this process (Jopling, 2010). Interestingly, these changes to the cytoarchitecture of 
cardiomyocytes and subsequent limited de-differentiation appear to resemble the effects 
of SMG (Fuentes, 2013) and MG on CPCs.  
Our laboratory has previously measured changes in microRNA expression in 
neonatal CPCs induced by SMG (Fuentes, 2013). In comparing those findings to the 
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microRNA changes induced by culture aboard the ISS, we found miR-99a and -100 as 
well as members of the let-7 family, all of which are implicated in differentiation and 
developmental regulation, exhibit significantly reduced expression under both conditions. 
Elsewhere, we have compared the effects of spaceflight and SMG on the induction of 
signaling in neonatal CCPs and observed similar activation of calcium and Akt signaling. 
When considered together these findings suggest that reduced gravity conditions readily 
alter the developmental properties of neonatal CPCs, possibly through reduced 
mechanotransduction (Baio, 2018). 
Alterations to microRNA expression as well as changes to ECM interactions in 
MG-treated CPCs highlight the significance of the environment in directing 
differentiation. For example, a single population of mesenchymal stem cells can express 
neurogenic, myogenic, or osteogenic transcription factors when cultured on soft, 
moderately stiff, or stiff matrices, respectively (Engler, 2006). In our experiments, we 
observed elevated expression of mesendodermal-stage developmental markers in 
neonatal CPCs. It is likely that ECM interactions prompted cytoskeleton remodeling 
while modifying intracellular signaling pathways such that proliferation and stemness 
were enhanced. Similar experiments in different cell types involving SMG or a low Earth 
orbit cell culture system have demonstrated that reduced gravity conditions modify the 
differentiation potential of stem cells. Mouse ESCs flown as embryoid bodies during the 
Space Tissue Loss Experiment exhibited a decrease in the expression of markers of 
terminal germ layer derivatives while maintaining expression of stem cell renewal 
markers (Blaber, 2015). However, upon return to Earth, these mouse ESCs differentiated 
more readily into colonies of contracting cardiomyocytes. Mesenchymal stem cells 
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cultured under conditions of SMG exhibit a reduction in the expression of markers of 
cartilage and osteoblast formation (Yuge, 2006; Dai, 2007), while also demonstrating 
enhanced proliferation potential and the maintenance or enhancement of stemness under 
SMG (Yuge, 2006; Zhang, 2015). 
In addition to the expression of genes that are indicative of an earlier stage of 
development, neonatal CPCs exhibited both a reduced capacity to readily form 
endothelial tubes and decreased expression of mesodermal derivative markers (i.e., 
cardiomyocte, endothelium, and osteoblast) under MG.  
This concomitant induction of mesendodermal markers and Tbx gene expression 
reflects the potential therapeutic value of the MG environment for cardiac repair. The 
critical role of the Tbx family in cardiac development has been well documented 
(Plageman, 2005) and its application to cellular therapies for cardiac repair is beginning 
to be explored. For example, SSEA-1+ early cardiovascular progenitors expressing T, 
TBX5, and TBX18, were shown to engraft into non-human primate myocardium 
following infarction (Blin, 2010). Meanwhile, Tbx5 and Tbx18 are expressed in highly 
migratory and proliferative proepicardial cell lineages (Tanaka, 2004; Hatcher, 2001). 
These studies have demonstrated an increasingly appreciated observation that Tbx 
expression is related to the engraftment and function of CPCs following transplantation.  
Beyond directing developmental events via alterations in intracellular signaling, 
disrupted cytoskeletal organization impacts migration. In other models, cytoskeletal re-
organization induces the expression of CXCR4, the SDF-1α chemokine receptor (Lin, 
2016). As seen in our experiments, both neonatal and adult CPCs exhibited elevated 
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expression of SDF1A, which correlates to the age-independent increase in migratory 
capacity of CPCs following spaceflight.  
Interestingly, the age-dependent changes in developmental status following 
culture aboard the ISS suggest fundamental differences in adult CPCs. While KEGG 
analysis demonstrated that functionally similar pathways are likely affected in both adult 
and neonatal CPCs, only the latter population experienced significant changes to the 
expression of cytoskeletal genes and early developmental markers. This trend was 
supported by the significantly increased cell cycle and proliferation patterns observed 
only in neonatal CPCs. Broad differences have already been reported to exist between 
adult and neonatal CPCs, including at the genetic/epigenetic (Fuentes, 2013) and 
proteomic levels (Sharma, 2017). In particular, the secretome of adult CPCs was found to 
exhibit a greater number of proteins related to anti-proliferation, pro-apoptosis, and 
senescence. Meanwhile, the secretome of neonatal CPCs exhibited higher levels of 
telomerases as well as proteins related to cell cycle, proliferation, and anti-apoptosis 
(Sharma, 2017). Similarly, we observed age-disparate responses to spaceflight in nearly 
all of these categories. In the context of this experiment, microRNA dysregulation may 
have exerted a greater effect on neonatal CPCs given their relatively higher levels of 
expression of genes related to these processes. Nevertheless, the prospective use of CPCs 
in autologous cardiac stem cell therapies in a predominately adult population requires that 
these functional differences be elucidated.  
As humans prepare to expand our presence in space, it is imperative to deepen our 
understanding of the nature of cellular adaptation to reduced gravity so that we may 
develop mechanisms by which these molecular changes in cardiac cell types can be 
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countered. Meanwhile, on Earth, we can further explore the therapeutic potential of these 
adaptations for cardiac repair. 
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CHAPTER THREE 
PROTEIN KINASE C ALPHA SIGNALING IS ACTIVATED  
BY REDUCED GRAVITY CONDITIONS AND  
VIA TREATMENT WITH WNT5A ON EARTH 
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Abstract 
As demonstrated in chapter two, neonatal cardiovascular progenitor cells (CPCs) 
experience alterations to gene expression and function in response to reduced gravity 
conditions. Furthermore, culture of neonatal CPCs aboard the International Space Station 
(ISS) was observed to promote migration and foster proliferation. Thus, the potential 
therapeutic benefit of culturing stem cells under conditions of simulated microgravity or 
spaceflight merit identifying the molecular events underpinning CPC adaptation to space. 
Therefore, following 12 and 30 days of culture aboard the ISS, neonatal CPCs were 
assessed for changes in gene expression and signaling activation. In doing so, we 
observed that ISS-cultured CPCs exhibited elevated levels of calcium handling and 
signaling genes, which corresponded to protein kinase C alpha (PKCα), a calcium-
dependent protein kinase, activation after 30 days. Additionally, Akt was activated, 
whereas phosphorylated Erk levels were unchanged. To explore the effect of calcium 
induction in neonatal CPCs, we activated protein kinase C alpha (PKCα) using hWnt5a 
treatment on Earth. Subsequently, early cardiovascular developmental marker levels were 
elevated. These findings demonstrate that calcium signaling is both sensitive to reduced 
gravity conditions and involved in directing the developmental profile of early 
cardiovascular progenitor cells. 
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Introduction 
The effects of spaceflight on cardiovascular progenitor cells (CPCs) critically 
impacts processes related to development and mechanotransduction via extracellular 
matrix interactions. Such findings relate to our observations under simulated 
microgravity, in which earlier developmental genes (Fuentes, 2015) and genes involved 
in non-canonical Wnt/Ca2+ signaling (Baio, 2018) were induced. Similar research that 
exposed neural crest progenitors to simulated microgravity observed increased AXIN2 
and GSK3β expression, whose protein products inhibit canonical Wnt signaling 
(Hatzistergos, 2018). In addition to the induction of non-canonical Wnt ligands, small 
RhoGTPases, such as RhoA, are intimately involved in calcium potentiation or inhibition 
(Kim, 2009). Thus, the more broadly observed involvement of RhoA in stem cell 
responses to simulated microgravity (Meyers 2005; Pan, 2007; Seki, 2006) likely 
implicate alterations to calcium activity in vivo. In the context of cardiogenesis, studies 
performed in both embryos and ESC-derived cardiomyocytes have shown a critical role 
of Ca2+ in regulating multiple steps of heart formation (Pucéat, 2005). Meanwhile, the 
modification of signaling pathways related to calcium, either as an important secondary 
or mediating molecule, directly impacts the ability of CPCs to differentiate or maintain 
pluripotency (Tonelli, 2012; Apati, 2016). Thus, we speculated that calcium activity may 
be intimately related to the response of early CPCs to reduced gravity conditions. 
For this reason, we sought to elucidate the role of calcium signaling in the response 
of CPCs to spaceflight and to identify peripheral pathways that may be involved in this 
process. We also sought to extend these space-borne observations to in vitro experiments 
on Earth.  
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Materials and Methods 
Ethics Statement/Cell Isolation and Expansion 
The Institutional Review Board of Loma Linda University approved the protocol 
for use of tissue that was discarded during cardiovascular surgery, without identifiable 
private information, for this study with a waiver of informed consent. CPCs were isolated 
from cardiac tissue of neonates (1 day – 1 month), as previously described (Fuentes, 
2013). Briefly, atrial tissue was cut into small clumps (approximately 1.0 mm3) then 
enzymatically digested using collagenase (Roche, Indianapolis, IN) at a working 
concentration of 1.0 mg/mL. The resulting solution was then passed through a 40-µm cell 
strainer. Cells were cloned in a 96-well plate by limiting dilution to a final concentration 
of 0.8 cells per well to create populations for expansion. Then, clones were screened for 
the co-expression of Isl1 and c-Kit and supplemented with growth media comprised of 
10% fetal bovine serum (Thermo Scientific, Waltham, MA), 100 µg/mL penicillin-
streptomycin (Life Technologies, Carlsbad, CA), 1.0% minimum essential medium non-
essential amino acids solution (Life Technologies, Carlsbad, CA), and 22% endothelial 
cell growth media (Lonza, Basel, Switzerland) in Medium 199 (Life Technologies, 
Carlsbad, CA). The MycoAlert PLUS Mycoplasma Detection Kit (Lonza, Basel, 
Switzerland) was used to test for mycoplasma contamination. 
Progenitor cell populations were fluorescently labeled with antibodies, as 
recommended by their respective manufacturers, and then analyzed using a MACSQuant® 
analyzer (Miltenyi Biotec, Auburn, CA). Quantification of data was performed using 
FlowJo software version 10 (Ashland, OR). Isotype controls and unstained cell populations 
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were used to define positive and negative gates. Antibodies used for cytometric analysis 
are described in Table 3. 
 
Biocell Seeding and Spaceflight 
For experiments described herein, neonatal CPCs were seeded into 8 polystyrene 
Biocells (BioServe Space Technologies, Boulder, CO) containing 20 mL of growth 
media. Biocells were loaded into self-contained environments containing 5% CO2 and 
95% air, and flown aboard SpaceX CRS-11 to the US National Lab on the ISS. Three 
days after launch, the Biocells arrived at the national lab, where they received fresh 
growth media and were placed in an incubator containing 5% CO2 and 95% air. 
Thereafter, fresh media was provided every four to five days while aboard the ISS 
(Figure 3). Biocells were seeded with CPCs derived from four unique neonates (1 day to 
1 month) before being fixed at 12 days after arrival to the ISS with RNA Protect (Qiagen, 
Valencia, CA) and stored at -80ºC or fed and returned to Earth at 30 days after arrival to 
the ISS for immediate processing. Clone- and passage-matched ground controls were fed 
and treated in parallel with the feeding schedule and activities performed by our astronaut 
collaborator aboard the ISS. 
 
Post-Flight Sample Processing 
Upon landing and retrieval of the payload, live cells were trypsinized, counted, 
and used to generate protein lysates. Biocells containing cells fixed and frozen in RNA 
protect were thawed at room temperature. The RNA protect was removed and centrifuged 
at 10,000g at 4ºC for 10 minutes. Biocells were disassembled and the culture membranes 
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were then rinsed with TRIzol® reagent (Life Technologies, Carlsbad, CA). RNA was 
purified from RNA protect samples using the RNeasy Mini Kit (Qiagen, Valencia, CA), 
per the manufacturer’s instructions, while total RNA was purified from TRIzol® reagent 
using isopropanol- and ethanol-based precipitation. cDNA was generated and RT-PCR 
was performed as described below. 
 
Gene Expression Profiler Array 
We used custom array plates (CLAH22469A; Qiagen, Valencia, CA) per the 
manufacturer’s instructions to measure gene expression changes in ISS-cultured adult and 
neonatal CPCs that were relevant to Wnt, ERK, BMP/Smad, and Notch signaling; 
cytoskeletal maintenance; calcium handling; apoptosis and cell cycle; cardiac 
development and stemness; and regeneration. Briefly, 2 µg of RNA was reverse 
transcribed into cDNA, as described above, and then thoroughly mixed with 2X RT2 
SYBR Green Mastermix and RNase- and DNase-free water before being loaded into the 
profiler array plate. Samples were amplified in the iCycler iQ™5 PCR Thermal Cycler 
(Bio-Rad, Hercules, CA) using a protocol of 95°C for 10 minutes and 40 cycles of 95°C 
for 15 seconds and 60°C for one minute. Fold changes were determined for each clone 
individually using the Qiagen Data Analysis Center (http://www.qiagen.com/ 
us/shop/genes-and-pathways/data-analysis-center-overview-page/) using GAPDH and 
ACTB (β-actin) as housekeeping genes. Since this analysis center performs only a two-
tailed Student’s t-test to calculate P-values, all fold changes for individual clones were 
exported to Prism and analyzed, as described below.  
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Quantitative RT-PCR 
cDNA was prepared using 2 µg of RNA with Superscript III (Life Technologies, 
Carlsbad, CA). Quantitative real-time polymerase chain reaction (qRT-PCR) was 
performed using Go-Taq® qPCR Mastermix (Promega, Madison, WI) and the iCycler 
iQ™5 PCR Thermal Cycler (Bio-Rad, Hercules, CA) following a protocol of 94°C for 10 
minutes followed by 45 cycles of 94°C for 15 seconds, 52–68°C (depending on the 
primer) for 60 seconds, and 72°C for 30 seconds. RT-PCR products were visualized 
using 1–2% agarose gel electrophoresis and low mass DNA ladder (Invitrogen, Carlsbad, 
CA). Primers were designed using the National Center for Biotechnology Information 
Primer-BLAST program and obtained from Integrated DNA Technologies (Coralville, 
IA). Primers used in experiments are listed in Table 7. 
 
Protein Simple-Based Western Blotting 
Following detachment, CPCs were homogenized using RIPA buffer containing 
phosphatase inhibitor cocktail (Millipore, Temecula, CA), followed by centrifugation at 
14,000 g for 15 minutes at 4°C and collection of the supernatant for analysis. Total 
protein concentrations were determined using the Pierce Micro BCA Protein Assay Kit 
(Thermo Scientific, Rockford, IL). A capillary-based western blotting system 
(ProteinSimple Wes, San Jose, CA) was used to assess protein expression. All procedures 
were completed according to the manufacturer’s instructions and default settings. The 
concentration of protein lysates, antibodies used in experiments, and antibody dilutions  
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  Table 7. Primer pairs used in RT-PCR for ISS experiments (5’ to 3’) 
 
Gene Forward Sequence  Reverse Sequence  
ACTIN  
TTTGAATGATGAGCCTTCGTC
CCC 
GTCTCAAGTCAGTGTACAGGT
AAGC 
CAMK2A GTCCAGTTCCAGCGTTCAGTT GTGGGGATTCAGGATGGTGG 
CCND1 TGCTGGAGTCAAGCCTGCGC AGGACATGCACACGGGCACG 
cMYC AAGACAGCGGCAGCCCGAAC TGGGCGAGCTGCTGTCGTTG 
GAPDH TGCACCACCAACTGCTTAGC GGCATGGACTGTGGTCATGAG 
JUN GTCCGCACTGATCCGCTCCG GGGCTGCGCGCACAAGTTTC 
MAPK1 TTCCCAGTTCTTGACCCCTG GTACATACTGCCGCAGGTCA 
MAPK3 ACCTACCTAAGGAGCGGCTG GGCCTCAGCAAAGGAGAGAG 
MAPK10 
TTGCACTCTGACCATGTTGGT
G 
TCATCAACCATCCACTTCCTGT
CT 
NFKB1 GCAGATGGCCCATACCTTCAA TTGTGAAGCTGCCAGTGCTA 
PDGFRA GCGCAATCTGGACACTGGGA ATGGGGTACTGCCAGCTCAC 
PIK3CA AACAATGCCTCCACGACCAT TCACGGTTGCCTACTGGTTC 
PLCG1 GCCCGACATCTGCCAAAGAA 
AGTCCATTGTCCACCACAAAC
T 
PRKCA TTTTCCCGGGCAACGACTC CGCACCCGGACAAGAAAAAG 
RELA GCGAGAGGAGCACAGATACC GGGGTTGTTGTTGGTCTGGA 
TGFB1 GGGCTACCATGCCAACTTCT GACACAGAGATCCGCAGTCC 
WNT3A CTGCCTGAGGGTGGGCTTTT TGGAACCTTCCCAGCTCGAC 
WNT5A 
CTTCGCCCAGGTTGTAATTGA
AGC 
CTGCCAAAAACAGAGGTGTTA
TCC 
WNT9A CAGCAGCAAGTTCGTCAAGC TTGCCCACCTCATGGAAAG 
WNT11 TCAGAATGTTCTGCGGGACC CCGAGTTCACTTGACGAGGC 
DUSP3 ATGCACGTCAACACCAATGC ATGCTCAGGGCAGACTTGAC 
POU5F1 
AACCTGGAGTTTGTGCCAGGG
TTT 
TGAACTTCACCTTCCCTCCAAC
CA 
MESP1 TAGGCCTCAGCGAGGAGAGT  TCCCTTGTCACTTGGGCTCC 
TBX3 TGGCCTACCATCCGTTCCTA GGACATCCACTGTTCCCCAG 
HXN4 CAGCCTCTTACGCCTGTTAC CCAGGAGTTGTTCACCATGTTG 
SHOX2 CTTACGGCGTTCGTCTCCAA GACACCTCCGTCAGTCGC 
NKX2-5 CGCCGCTCCAGTTCATAG GGTGGAGCTGGAGAAGACAGA 
TBX5 CTCAGTCCCCCGGAACAAC CACGTACCTCCCAGCTCAAG 
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are indicated in Table 8. A positive control for phosphorylated Akt (Cell Signaling 
Technology, Danvers, MA; catalog number 9273S, lot number 20) was diluted 1:2. The 
anti-rabbit and anti-mouse secondary antibodies included in the Wes Detection Module 
kit (ProteinSimple, San Jose, CA) were used. All data were analyzed with the Compass 
Software associated with the Wes instrument (ProteinSimple, San Jose, CA). Data were 
exported to Prism for further analysis, as described below.  
 
hWnt5a Treatment of CPCs 
Neonatal CPCs were grown until approximately 85% confluent and treated with 
100ng/mL recombinant human/mouse Wnt5a (R&D Systems, Minneapolis, MN) in CPC 
growth media for 1 hour, a concentration and duration that were previously shown to 
induce protein kinase C activity (Koyanagi, et al, 2009). Cells were then washed with 
PBS and placed in TRIzol® reagent or formed into protein lysates, as described by 
Abrahamsen, et al. (2013). RT-PCR and western blotting were performed, as described 
above. 
 
Statistical Analysis 
 The Shapiro-Wilk test for normality was used to test the normality of data 
distribution. Student’s t-test was used to compare the mean of all normally distributed 
data. Non-normally distributed data were compared using a Wilcoxon matched-pairs 
signed rank text. For protein expression analysis, either Student’s t-test or Mann-Whitney 
U test was used to compare the mean of normally or non-normally distributed data, 
respectively. All data are reported as the mean ± the standard error of the mean. Prism 7 
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version 7.02 (GraphPad, La Jolla, CA) was used for all statistical analyses. P values < 
0.05 were assumed to indicate statistical significance.  
 
Results 
Flight aboard the ISS Activates PKCα in Neonatal CPCs 
Observations under both simulated microgravity (SMG) and after culture aboard 
the International Space Station (ISS) prompted us to determine whether calcium handling 
and signaling were altered by spaceflight. We evaluated the expression of genes involved 
in regulating intracellular calcium levels and subsequent signaling events in neonatal 
CPCs after flight aboard the ISS and observed significantly elevated levels of RYR2 
(5.265 ± 1.508-fold change, P<0.05, n=3), CACNA1S (8.059 ± 1.771-fold change, 
P<0.05, n=3), and CAMK2A (5.979 ± 1.289-fold change, P<0.05, n=3) (Figure 19A). 
Changes in calcium handling at 12 days suggested an ultimate induction of calcium 
signaling at 30 days, which was supported by significantly elevated levels of PLCG1 
(6.041 ± 0.527-fold change, P<0.01, n=3), PRKCA (4.482 ± 0.617-fold change, P<0.01, 
n=3), and CAMK2A (3.982 ± 0.540-fold change, P<0.01, n=3) transcripts (Figure 19B). 
Moreover, we assessed a significant increase in phosphorylated protein kinase C alpha, a 
calcium-dependent protein kinase C (P-PKCα: 1.448 ± 0.065-fold change, P<0.01; P-
PKCα/PKCα: 1.298 ± 0.058-fold change, P<0.05; P-PKCα/GAPDH: 1.466 ± 0.088-fold 
change, P<0.05; n=3–4) after 30 days of ISS culture (Figure 20A-B). Such ISS-mediated 
changes to calcium signaling may have a direct impact on cardiogenesis, as shown in the 
schematic in Figure 20C. 
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     Table 8. Antibodies used for western blot experiments of ISS-cultured and hWnt5a-treated neonatal CPCs 
 
Antibody Manufacturer Sample Used Antibody 
Dilution 
Species Clone Catalog No. Lot No. 
GAPDH Cell Signaling 0.4 mg/mL 1:50 Mouse D4C6R 97166T 3 
AKT (pan) Cell Signaling 0.04 mg/mL 1:50 Rabbit C67E7 4691S 17 
Phospho-AKT (Ser473) Cell Signaling 0.4 mg/mL 1:10 Rabbit D9E 4060S 23 
p44/42 MAPK (Erk1/2) Cell Signaling 0.04 mg/mL 1:25 Rabbit 137F5 4695S 14 
Phopsho-p44/42 MAPK 
(Erk1/2) (Th202/Ty204) 
Cell Signaling 0.4 mg/mL 1:10 Rabbit D13.14.4E 4370S 12 
PKCα Cell Signaling 0.04 mg/mL 1:25 Rabbit Polyclonal 2056T 4 
Phospho-PKCα/β II 
(Thr638/641) 
Cell Signaling 0.04 mg/mL 1:10 Rabbit Polyclonal 9375T 4 
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Figure 19. Spaceflight activates protein kinase C alpha in neonatal CPCs after 12 days  
After 12 days aboard the ISS, neonatal CPCs were fixed and induction of genes involved 
in calcium handling was measured via RT-PCR (A). Calcium handling alterations at 12 
days led to the induction of genes involved in calcium signaling at 30 days (B). n=3 per 
group for RT-PCR; *p<0.05, **p<0.01, ***p<0.001. Fold changes are shown as the mean 
± S.E.M. 
A    B 
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Figure 20. Spaceflight activates protein kinase C alpha in neonatal CPCs after 30 days 
After 30 days aboard the ISS, protein lysates were made from pooled neonatal clones. 
Phosphorylated PKCαβ, PKCα, and GAPDH protein levels were determined in technical 
replicates (A-B). ISS-culture mediates changes to calcium signaling that impact 
cardiogenesis (C) n=3 measurements of four pooled neonatal clones for protein analysis; 
*p<0.05, **p<0.01, ***p<0.001. Fold changes are shown as the mean ± S.E.M.
A
B
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Flight aboard the ISS Activates Akt in Neonatal CPCs 
These findings of increased expression of calcium-related signaling prompted us 
to assess the role of calcium-sensitive pathways that are pertinent to stem cell physiology 
(i.e., ERK and Akt). We assessed the expression of Akt-related signaling genes in 
neonatal CPCs after 12 and 30 days of flight aboard the ISS. At 12 days, we observed 
significantly elevated levels of PIK3CA (2.216 ± 0.343-fold change, P<0.01, n=9), cMYC 
(4.811 ± 1.341-fold change, P<0.05, n=9) and NFκB1 (2.704 ± 0.528-fold change, 
P<0.05, n=9). At 30 days, we observed significantly elevated levels of PIK3CA (7.764 ± 
0.472-fold change, P<0.001, n=3), CCNDI (3.257 ± 0.195-fold change, P<0.01, n=3), 
cMYC (3.297 ± 0.309-fold change, P<0.01, n=9), JUN (4.997 ± 0.213-fold change, 
P<0.001, n=3), NFκB1 (5.935 ± 0.830-fold change, P<0.01, n=3), and RELA (2.799 ± 
0.291-fold change, P<0.01, n=3) (Figure 21). Protein expression analysis revealed an 
induction of phosphorylated Akt following spaceflight when normalized to GAPDH or 
analyzed as total substrate (P-AKT: 1.573 ± 0.152-fold change, P<0.05; P-AKT/GAPDH: 
1.812 ± 0.176-fold change, P<0.05; n=3) after 30 days of ISS culture (Figure 22A-B). 
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Figure 21. Spaceflight activates Akt signaling in neonatal CPCs 
After 12 and 30 days aboard the ISS, neonatal CPCs were fixed and gene expression along 
the Akt pathway was measured via RT-PCR. n=3–9 per group for RT-PCR; *p<0.05, 
**p<0.01, ***p<0.001. Fold changes are shown as the mean ± S.E.M. 
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          A 
B
Figure 22. Spaceflight activates Akt signaling in neonatal CPCs 
After 30 days aboard the ISS, neonatal CPCs were fixed and protein lysates were made 
from pooled neonatal clones. Then, phosphorylated Akt, Akt, and GAPDH protein levels 
were determined in technical replicates (A) and quantified (B). n=3–9 per group for RT-
PCR and n=3 measurements of four pooled neonatal clones for protein analysis; *p<0.05, 
**p<0.01, ***p<0.001. Fold changes are shown as the mean ± S.E.M. 
(+)   (-) 
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ERK/MAPK is Not Activated in Neonatal CPCs by Spaceflight 
This change in Akt activity prompted us to investigate whether ERK/MAPK 
signaling was altered by spaceflight. We evaluated the expression of ERK/MAPK-related 
signaling genes in neonatal CPCs after 12 and 30 days of flight aboard the ISS (Figure 
23-24). At 12 days, we observed significantly reduced levels of DUSP3 (0.280 ± 0.126-
fold change, P<0.01, n=3), which encodes a phosphatase involved in the deactivation of 
ERK/MAPK signaling. Interestingly, the targets of ERK/MAPK signaling were also 
elevated: GRB2 (11.660 ± 2.709-fold change, P<0.05, n=3) and RAF1 (5.230 ± 0.762-
fold change, P<0.01, n=3) (Figure 23A-B). However, at 30 days, the induction of genes 
along this signaling pathway was muted. Moreover, we observed no increase in 
phosphorylated ERK after 30 days of ISS culture (Figure 24A-B). 
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Figure 23. Spaceflight does not activate Erk signaling in neonatal CPCs  
After 12 and 30 days aboard the ISS, neonatal CPCs were fixed and gene expression along 
the ERK/MAPK pathway was measured via RT-PCR. At 12 days, ERK/MAPK pathway 
(A) and target (B) gene expression was generally elevated; however, at 30 days, such
pathway gene expression was largely muted (A). n=3 per group for RT-PCR; *p<0.05,
**p<0.01. Fold changes are shown as the mean ± S.E.M.
A 
B 
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Figure 24. Spaceflight does not activate Erk signaling in neonatal CPCs  
Protein lysates were generated from pooled neonatal clones after 30 days aboard the ISS 
and phosphorylated ERK1/2, ERK1/2, and GAPDH protein levels were determined in 
technical replicates (C-D). n=3 per group for RT-PCR and n=3–4 measurements of four 
pooled neonatal clones for protein analysis; *p<0.05, **p<0.01. Fold changes are shown 
as the mean ± S.E.M. 
A
B
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Ca2+ Signaling Contributes to Induction of Genes Involved in Early Cardiogenesis 
Given the role of calcium signaling in mediating the effects of spaceflight in 
neonatal CPCs, we sought to assess the effects of such signaling on the ground. Neonatal 
CPCs were treated with recombinant hWnt5a (100ng/mL) for 1 hour, which is a 
concentration and duration that were previously shown to induce PKC activity 
(Koyanagi, et al, 2009). We then investigated the induction of canonical and non-
canonical Wnt ligands (Figure 25A) and calcium signaling genes (Figure 25B): WNT5A 
(3.027 ± 0.087-fold change, P<0.01, n=3), WNT9A (4.587 ± 0.485-fold change, P<0.05, 
n=3), WNT11 (3.713 ± 0.297-fold change, P<0.05, n=3), PLCG1 (4.609 ± 0.544-fold 
change, P<0.05, n=3), PRKCA (28.190 ± 2.658-fold change, P<0.01, n=3), and CAMK2A 
(342.700 ± 37.760-fold change, P<0.05, n=3). The induction of PKCα phosphorylation 
indicated the presence of calcium activity (P-PKC/PKC: 1.635 ± 0.072-fold change, 
P<0.05, n=3; (Figure 25C-D). This occurred concomitantly with the induction of early 
developmental genes (Figure 25E), including the pluripotency marker POU5F1 (3.453 ± 
0.194-fold change, P<0.05, n=3) and the mesodermal marker MESP1 (23.760 ± 1.230-
fold change, P<0.01, n=3).  
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Figure 25. Non-canonical Wnt/Ca2+ signaling impacts the developmental phenotype of neonatal CPCs 
Wnt5a treatment of neonatal CPCs for 1 hour induces expression of non-canonical Wnt ligands (A), genes involved in 
the non-canonical Wnt/Ca2+ pathway (B), and calcium-dependent PKCα activation (C-D). Induction of genes along this 
pathway occurred concomitantly with modifications in expression of markers of early cardiogenesis (E). n=3; *p<0.05, 
**p<0.01, ***p<0.001. Changes in gene expression are shown as the mean ± S.E.M. 
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Sinoatrial Nodal Genes Are Induced by Calcium Pathway Activity 
Increasing evidence indicates that sinoatrial nodal cells represent a population of 
embryonic myocardium that retains its primitive phenotype (Bakker, 2010). For this 
reason, we assessed the relationship between primordial cardiogenesis gene induction and 
that of the sinoatrial nodal gene program in Wnt5-treated CPCs (Figure 26). We observed 
significant increases in the expression of TBX3 (5.212 ± 0.917-fold change, P<0.05, n=3), 
TBX5 (7.678 ± 0.178-fold change, P<0.01, n=3), SHOX2 (6.318 ± 0.813-fold change, 
P<0.05, n=3), and HCN4 (9.489 ± 1.191-fold change, P<0.05, n=3) along with decreased 
expression of NKX2-5 (0.237 ± 0.044-fold change, P<0.05, n=3).  
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Figure 26. SAN gene induction via calcium signaling activation 
Wnt5a treatment of neonatal CPCs induces sinoatrial nodal gene and protein expression. 
The primordial phenotype of Wnt5a-treated CPCs included the induction of sinoatrial 
nodal genes. n=3; *p<0.05, **p<0.01, ***p<0.001. Changes in gene expression are shown 
as the mean ± S.E.M. 
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Discussion 
Culture aboard the ISS resulted in the activation of calcium-dependent protein 
kinase C (PKCα) and Akt in neonatal CPCs. This increase in calcium signaling was 
modeled in vitro on Earth using hWnt5a, a non-canonical ligand that promotes protein 
kinase c activation. We observed an important role in calcium signaling in accounting for 
the effects, at least in part, of spaceflight within neonatal CPCs. 
Among the changes experienced by CPCs during spaceflight, we found that 
calcium pathway genes and those related to calcium handling were expressed at higher 
levels following culture aboard the ISS as well as under SMG, though to a more modest 
extent. These changes in calcium extend beyond human CPCs. During spaceflight, 
calcium loss is widely observed in astronauts and is usually linked to changes in bone 
metabolism (Smith, 2012). Yet, in one animal model of SMG, mice were observed to 
exhibit an increased incidence of arrhythmias along with alterations in intracellular 
calcium handling, including ryanodine receptor (RyR2) phosphorylation (Respress, 
2014). Moreover, short-duration atrial fibrillation, premature ventricular contractions, and 
ventricular tachycardia have all been reported in astronauts during spaceflight (Anzi, 
2014). Importantly, while the etiology of such cardiac events during spaceflight remains 
unknown, disturbances in calcium handling may be an important contribution to cardiac 
abnormalities in space. 
Meanwhile, the modification of signaling pathways related to calcium, either as 
an important secondary or mediating molecule, directly impacts the ability of CPCs to 
differentiate or maintain pluripotency (Tonelli, 2012; Apati, 2016). The effect of calcium 
signaling is dependent both on the pathway in which it is involved as well as the species 
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under study, with mouse ESCs exhibiting far different responses to calcium-mediated 
activity compared to human ESCs. For example, calcium signaling promotes 
pluripotency in hESCs, while being affiliated with differentiation in mESCs (Tonelli, 
2012). In the context of cardiogenesis, studies performed in both embryos and ESC-
derived cardiomyocytes have shown a critical role of Ca2+ in regulating multiple steps of 
heart formation (Pucéat, 2005). For example, induction of Ca2+ oscillation promotes 
proliferation and, upon transplantation, enhances engraftment and expansion (Ferreira-
Martins, 2009). In this way, our observed shift in expression of markers of early cardiac 
development is likely the result, at least in part, of modified calcium signaling activity 
within neonatal CPCs. Furthermore, research into Mesp1-expressing pre-cardiac 
mesoderm derived from human ESCs exhibited enriched activity along the calcium, 
extracellular matrix-receptor, and Wnt signaling pathways at day 5 of development (den 
Hartogh, 2016), which is supported by our observed increase in markers of such a state of 
development after culture aboard the ISS. Meanwhile, Akt signaling via calcium 
activation has been well documented to promote the maintenance of pluripotency in 
hESCs (Tonelli, 2012). Additionally, Akt signaling exerts a critical role in several cell 
functions that are relevant to stem cell transplantation, migration, and cytokine 
expression (Manning, 2007). Therefore, manipulating calcium signaling on Earth and 
promoting Akt activation presents a novel therapeutic opportunity for cell-based cardiac 
repair.  
In addition to modifying intracellular calcium signaling, the expression of non-
canonical Wnt ligands has been observed in association with the cryoinjury response of 
the neonatal rodent heart (Mizutani, 2016). Since WNT5A and PRKCA gene expression 
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induction is involved in the response of neonatal CPCs to SMG, we sought to assess the 
potential role of Wnt5a in promoting enhanced stemness in CPCs. While preliminary, 
these early results indicate a relationship between enhanced intracellular calcium 
signaling as well as increased expression of markers of early cardiogenesis in neonatal 
CPCs. The expression of early cardiogenic mesoderm markers indicates a potentially 
earlier developmental state. In addition to being linked to enhanced therapeutic potential 
following transplantation (Menasché, 2015; Behfar, 2010; Bartunek, 2013; Blin, 2010), 
such an early developmental state may also provide the appropriate cell source for 
biological pacemaker development. In an avian model, Bressan et al. used fate mapping 
to determine that sinoatrial nodal cells were observed to already be specified shortly after 
gastrulation prior to the onset of cardiogenesis within a region that was observed to be 
Nkx2-5- and Isl1-negative (Bressan, 2013). Meanwhile, the Keller group recently 
reported a method of generating sinoatrial nodal-like pacemaker cells in Nkx2-5-negative 
cardiomyocytes (Protze, 2017). Similarly, we observed decreased NKX2-5 and ISL1 
expression under both SMG and MG. When considered together, our findings using 
simulated and real MG support the emerging hypothesis that sinoatrial nodal cells 
represent a de-/un-differentiated state of cardiac development (Bakker, 2010). Moreover, 
our observation that calcium signaling has an integral role in this process is mirrored by 
observations that Wnt7a, which mobilizes intracellular calcium (Thrasivoulou, 2013), has 
been observed in the developing cardiac conduction system (Gessert, 2010). Given the 
observed changes to the expression of calcium handling genes and proteins, future studies 
should assess the effect of SMG and ISS-culture on intracellular Ca2+ transients and the 
electrophysiological properties of CPCs. 
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Notably, the increased expression of sinoatrial nodal markers may reflect the 
emerging hypothesis that this unique functional cell type develops from myocardium that 
retains its primitive phenotype (Bakker, 2010). Accordingly, the concomitant increased 
expression of sinoatrial nodal genes and decreased expression of other mesodermal 
derivatives indicates that the reduced gravity conditions of spaceflight promote the 
modest de-differentiation of neonatal CPCs. In our previous chapter, we documented an 
significant decrease in the expression of microRNA-106b, which otherwise would repress 
the induction of the sinoatrial nodal gene program. Additionally, the elevated expression 
of Tbx proteins, particularly, Tbx3, overlaps with previous reports in the regulation of 
pre-mesoderm (i.e., mesendoderm) gene expression (Weidgang, 2013). As described in 
Baio et al. (2018), a similar induction of the sinoatrial nodal gene program was observed 
in SMG-treated CPCs: TBX3 (141.600 ± 54.550-fold change, P<0.05, n=3), TBX5 
(35.620 ± 4.667-fold change, P<0.05, n=3), HCN4 (48.510 ± 18.710-fold change, 
P<0.05, n=3), and NKX2-5 (0.146 ± 0.042-fold change, P<0.001, n=3).  
Importantly, many of these processes observed reduced gravity conditions are 
dependent upon the developmental status of the cell. Indeed, later stages of cardiogenesis 
and the incipient developmental cues of embryonic stem cells all respond differently to 
calcium and Wnt signaling (Ueno, 2007; Cohen, 2008; Ozhan, 2015). Therefore, 
understanding the effects of mechanical transduction and altered intracellular calcium 
signaling within the myriad cell types that constitute the human body will help inform 
medical interventions that will be necessary to sustain deep space missions. Meanwhile, 
the molecular events that constitute microgravity sensing can be manipulated on Earth to 
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facilitate regeneration. In doing so, microgravity-inspired, cell-based therapies can be 
developed. 
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CHAPTER FOUR 
ANGIOTENSIN II TREAMENT OF NEONATAL  
CARDIOVACULAR PROGENITOR CELLS INDUCES THE  
DEVELOPMENT OF SINOATRIAL NODAL-LIKE CELLS 
 
Abstract 
The cardiac pacemaker has been used to treat arrhythmias that arise from 
dysfunction of the sinoatrial node (SAN), which generates the pacing activity of the 
heart. Though these pacemakers are limited in responsiveness to autonomic regulation 
and require routine maintenance, no alternative therapies exist. Primordial Islet-1+ 
cardiovascular progenitor cells (CPCs) differentiate into functional pacemaker cells 
during development. Transcription factors from the T-box family, including Tbx3, Tbx5, 
and Tbx18, are implicated in this process. We have previously shown that simulated 
microgravity, International Space Station culture, and hWnt5a treatment induced activity 
along the phospholipase C (PLC)/protein kinase C alpha (PKCα)/calcium signaling axis 
and that these conditions correlated with the induction of sinoatrial nodal-related gene 
expression. Therefore, we induced PLC/PKCα/Ca2+ signaling via angiotensin II receptor 
type I activation to differentiate Islet-1+ human neonatal-derived CPCs into functional 
SAN cells that express the characteristic funny (i.e., pacemaker) current-carrying 
hyperpolarization-activated cyclic nucleotide gated (Hcn4) channel. Following treatment 
with angiotensin II for 72 hours, RT-PCR was used to assess expression of genes of the 
SAN gene program, which was found to be induced. This resulted in a 7.75-fold increase 
in Hcn4 protein induction, as indicated by western blotting. Furthermore, cardiomyocyte 
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markers, including transcripts of TropT and Cxn43, were all significantly decreased in 
expression. Treated CPCs were then stained with fluo4-AM, an intracellular calcium dye, 
imaged using confocal microscopy, and observed for the presence of an auto-rhythmic 
calcium flux. Electrophysiology recordings of treated cells in the whole cell, perforated 
patch configuration revealed an action potential of -40 ± 1 mV, a slow maximum 
upstroke velocity of dV/dtmax < 10 V/s, and an epinephrine sensitivity that accelerated the 
number of action potentials from 1.05 ± 0.05 to 1.41 ± 0.05 per second. 
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Introduction 
Atrial arrhythmias represent a group of common medical conditions that annually 
affect more than three million individuals in the United States (NHLBI, 2014). While 
many of these patients can address these fibrillations through changes in lifestyle, 
expanded access to resources related to health improvement, or with medication, over 
180,000 annual patients still require an exogenous pacemaker (Greenspon, 2012). Many 
complications can result from both implanting and using a pacemaker, including 
infections during implantation, parenchyma erosion, hemo- and pneumothorax, 
pacemaker migration or dislodgement, and venous thrombosis (Gul, 2011). Lead 
displacement occurs in 5–10% of pacemaker recipients (National Pacemaker and ICD 
database, 2001), while pacemaker syndrome (i.e., atrioventricular asynchrony) and other 
long term complications of pacemakers are estimated to occur in approximately 2.7% of 
patients (Trohman, 2004). For children who are born with a congenital arrhythmia, 
pacemaker implantation must be performed regularly to keep pace with the developing 
size of the child (Cho, 2015). Among all patients, magnetic interference, such as from 
portable headphones (Lee, 2009) and magnetic resonance imaging scanners (Kalin, 
2005), are clinical concerns due to their ability to induce asynchronous pacing. For this 
reason, a biological pacemaker, such as a CPC-derived sinoatrial node, has been the 
subject of recent research efforts. 
 
Application of Reduced Gravity Conditions on Earth 
Lessons for sinoatrial nodal development may be informed by studies of 
cardiovascular precursors under conditions of microgravity. Simulated microgravity has 
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been shown in our lab and elsewhere to result in the expansion of pacemaker cells or of 
markers of the sinoatrial nodal gene program (Hatzistergos et al., 2018; Baio, 2018). We 
also demonstrated in Baio et al. (2018) that TGFB1 expression was induced under these 
conditions, which supports recent work by the laboratory of Ann C. Foley, who 
demonstrated that MAP3K7, or TGFß-activated kinase 1, overexpression in mouse 
embryonic stem cells faithfully induced sinoatrial node development (Brown, 2017). 
Indirectly, the reduction in NKX2-5 expression in cardiovascular progenitors 
during spaceflight indicates that reduced gravity conditions may prime the cell population 
under study to assume a sinoatrial nodal gene expression profile. As shown in Bressan et 
al. (2013) and Protze et al. (2017), pacemaker cells are specified shortly after gastrulation 
and prior to the onset of cardiogenesis in a population of Nkx2-5-negative cells. This is 
mirrored by a similar reduction in Nkx2.5 expression in SMG-treated CPCs, whose 
sensitivity to gravity is modulated, at least in part, by calcium signaling (Baio, 2018). 
Interestingly, calcium signaling has been shown to be activated in the developing cardiac 
conduction system via Wnt7a induction (Gessert, 2010), which mobilizes intracellular 
calcium (Thrasivoulou, 2013).  
In particular, the association between sinoatrial nodal gene program induction and 
calcium signaling under simulated microgravity (Baio, 2018), during culture aboard the 
International Space Station, and following treatment with hWnt5a, indicates that calcium 
potentiation may be one method of creating an enriched sinoatrial nodal cell population 
on Earth. Various pathways can achieve this end, including non-canonical Wnt signaling 
(e.g., Wnt5a) and angiotensin II receptor type I activation (Figure 27). While both 
processes may be applied, the latter has been carefully studied in the cardiac context. In 
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rodent models, angiotensin II receptor activation increases ERK phosphorylation, nuclear 
[Ca++] levels, and proliferation (Tadevosyan, 2012). Moreover, angiotensin II receptor 
type I activation and antagonism has been shown to modulate hyperpolarization 
activated, cyclic-nucleotide gated potassium/sodium channel 4 (Hcn4) and the sinoatrial 
nodal-characteristic funny current (Xu, 2009). Finally, pacemaker-like cells have been 
shown to directly be induced from mouse cardiac progenitor cells via angiotensin II 
treatment (Xue, 2015). Thus, we sought to test whether the sinoatrial nodal-like 
phenotype that emerges following exposure of progenitor cells under reduced gravity 
conditions is mediated, at least in part, by calcium signaling. The molecular biology of 
sinoatrial nodal development has been discussed earlier (chapter one), while the 
functional properties governing sinoatrial nodal cell function are described below. 
Knowledge of these properties is foundational to verifying the authenticity of sinoatrial 
nodal cell induction.   
 
Functional Properties of the Sinoatrial Node 
Beginning in the 1800s, the individual efforts of Jan E Purkinje, Wilhelm His, and Sunao 
Tawara collectively initiated the elucidation of the conduction system of the heart 
(Silverman, 2007). Then, in 1906, Martin Flack and Arthur Keith identified a structure 
that was located at the junction of the superior vena cava and the right atrium of the heart 
(Keith, 1907). Given its resemblance to the then-recently identified atrioventricular node 
(Tawara, 1906), Flack and Keith identified this as the sino-auricular node (Silverman, 
2007). Subsequent electrophysiology studies confirmed the postulated function of this 
node as well as resulted in the use of its present name, the sinoatrial node (Lewis). 
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Figure 27. Angiotensin II receptor type I activation 
induces calcium signaling (Baio, 2018) 
As in simulated microgravity, angiotensin II receptor type 
I activation activates phospholipase C (PLCG1), 
potentiates calcium, and activates protein kinase C alpha 
(PRKC). Ultimately, broad cellular activities are modified, 
including migration, proliferation, and development. 
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The sinoatrial node initiates the cardiac conduction system in an automated 
fashion. While other nodes, such as the atrioventricular node, have their own pacing 
potential, they are suppressed by the higher frequency (60–100 bpm) of the sinoatrial 
node. The higher frequency of sinoatrial node firing prevents downstream nodes from 
reaching their pacing potential threshold (Vassalle, 1977). For this reason, the sinoatrial 
node is often considered the pacemaker of the heart.  
This automaticity is derived from a series of inward- and outward-directed ion 
channels (Verkerk, 2007). As shown in Figure 28, following the conclusion of an action 
potential, there is a slow, positive increase in voltage across the sinoatrial nodal cell 
membrane (i.e., the pacing potential). When the pacing potential reaches the action 
potential threshold, a new action potential is fired (Berne, 2004). This slow, positive 
increase is an important feature of the sinoatrial node. Unlike the resting membrane 
potential of cardiomyocytes, which is generally stable, the sinoatrial node’s resting 
membrane potential is constantly and slowly increasing from an average potential of -
70mV to the average threshold of -40mV (Sherwood, 2012). It is also here where the 
autonomic nervous system can modulate the rhythm of the heart by accelerating 
(sympathetic) or decelerating (parasympathetic) the increase in the resting membrane 
potential (Brown, 1979; Bucchi, 2007; Di Francesco, 1991, 2010).  
A variety of ion channels produce the electrical conduction activity of the sinoatrial node 
(Cho, 2015; Verkerk, 2007), while the regulation of these ion channels, such as by 
secondary signaling molecules, modulates its automaticity (Sah, 2014; Bucci, 2007). 
During the slow pacing phase of the heart cycle, or diastolic depolarization in which 
blood is filling the chambers prior to sinoatrial node action potential firing and signal 
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propagation, inward ion currents are activated while outward ion currents are deactivated 
(Verkerk, 2007). Among the currents that are produced by the activated channels of 
diastolic depolarization, the hyperpolarization-activated pacemaker current, or the funny 
current (If), is considered to be the principal component of the pacemaker and accounts 
for the autonomic sensitivity of the sinoatrial node and is often implicated in age-related 
heart conditions (Di Francesco, 1993, 2007; van Ginneken, 1991; Accili, 1997, Verkerk, 
2003; Zicha, 2005). The hyperpolarization activated cyclic nucleotide gated potassium 
channel 4 (Hcn4) is a molecular constituent of the pacemaker current-carrying channel 
(Stieber, 2004), thereby contributing to its mixed potassium and sodium constitution. In 
response to hyperpolarization (between -70 mV to -40 mV), the pacemaker current is 
activated. Furthermore, the secondary messenger, cyclic adenosine monophosphate 
(cAMP), regulates diastolic depolarization. In response to sympathetic activation, cAMP 
levels increase, thereby increasing the rate of pacemaker current activation and 
accelerating the pace of action potential firing in the sinoatrial node (Di Francesco, 1991, 
2007). Additional currents that are produced by channel activation during diastolic 
depolarization include the calcium-release activated sodium-calcium exchange current 
(INCX), the sustained inward current (Ist), the sodium current (INa), and the T- and L-type 
calcium currents (ICa,T and Ica,L) (Verkerk, 2007). Despite the work of Di Francesco and 
his colleagues in characterizing the role of the pacemaker (i.e., funny) current in pacing, 
there is controversy over the significance of this current. Other investigators have argued 
that INa and Ica,L are the principle currents of the sinoatrial node (Boyett, 2000). Both 
arguments are supported by substantial evidence, suggesting that these currents behave 
synergistically, and perhaps in a location-specific manner, to contribute to the slight  
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Figure 28. SAN pacing currents (Klabunde, 2011) 
Ionic currents drive the gradual depolarization that is 
characteristic of the SAN. If: funny current; iCa(T): T-type 
calcium current; iCa(L): L-type calcium current; iK: 
potassium current.  
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increase in resting membrane potential that accounts for the automaticity of the sinoatrial 
node. 
Interestingly, it has been reported that a radial distribution of cell morphologies 
exist in the sinoatrial node (Boyett, 2007). The most archetypal pacemaker cells exist in 
the center, or leading pacemaking site, of the SAN. These cells are smaller, poorly 
organized, and without many mitochondria. More peripherally, there are atrial-like cells 
that are still involved in automated electrical conduction but interdigitate and function 
synergistically with the surrounding atrial tissue. These peripheral cells are observed to 
be larger and express connexin channel 40 (Cx40) as well as the sodium transporter, 
NaV1.5. This radially organized and heterogeneous fine architecture of the SAN 
facilitates its function as peripheral channels may be more resilient to hyperpolarization 
currents that are derived from atrial tissue, thereby guaranteeing the unidirectional 
propagation of the pacing potential. Histologically, an abundance of collagen and 
fibroblasts and an underlying layer of atrial muscle have been observed, perhaps 
conferring protection to the SAN against atrial wall stress (Boyett, 2000; Dhein, 2009).  
Upon reaching the threshold potential for action potential initiation, the sinoatrial 
node propagates the signal through connexin channel 45 (Cx45; Lo, 2000; Dhein, 2010) 
into the adjacent atrial cells, thereby inducing atrial contraction and moving blood from 
the atrium into the ventricles. The gradual intercellular coupling that is afforded by the 
above-described spatial distribution allows the propagation of the action potential into the 
atria (Boyett, 2000). This signal eventually arrives at the atrioventricular node, which 
then descends, following a brief delay that allows the ventricles to fill with blood, down 
the ventricles through the bundle of His to be terminally distributed through the Purkinje 
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fibers as well as through the right and left bundle fibers. This final distribution of 
electrical activity results in ventricular contraction by cardiomyocyte activity, which 
moves blood from the heart to either the pulmonic or systemic circulation. These 
cardiomyocytes rapidly depolarize following a rapid influx of sodium ions that is occurs 
after rapid sodium channels open under the influence electrical activity that is transported 
from neighboring cells through connexins. These sodium channels are then inactivated 
while potassium and chlorine channels transiently open, allowing for a small decrease in 
membrane potential that is characteristic of cardiomyocytes. The membrane potential 
then plateaus due to a balance between an inward calcium current and an outward 
potassium current. (Sherwood, 2012). Finally, cardiomyocytes experience a rapid 
repolarization following the closure of the calcium current producing channels. While 
cardiomyocytes are generally under the influence of the sinoatrial node, cardiomyocytes 
can independently contract (Satin, 2004). Indeed, embryonic stem cell-derived 
cardiomyocytes have already been shown to be able to develop self-generating rhythms 
of contraction (Kehat, 2004).  
The heart is susceptible to atypical pacing following exposure to adverse 
conditions. For example, following hypoxia, persistent sodium current is observed to 
increase after cardiomyocyte depolarization (Ju, 1996). Additionally, Weisfeldt et al. 
(1974) demonstrated the loss of a healthy cardiac conduction cycle that was characterized 
by a loss of complete relaxation following an action potential. Meanwhile, under 
conditions of microgravity, such as during spaceflight, heart rate appears to be altered or 
become variable, possibly due to changes in susceptibility to autonomic influence 
(Migeotte, 2003; Xiao, 2004). Therefore, studies of pacing in CPC-derived sinoatrial 
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nodal cells can intuitively be extended to include studies of automaticity in 
cardiomyocytes following adverse conditions. 
Therefore, we sought to develop cells that could ultimately form the basis for 
biological pacemaker development in vitro. To achieve this end, we applied the 
mechanisms observed in CPCs during spaceflight on Earth. We then screened the 
induction of the sinoatrial nodal gene program and of Hcn4 protein. We concluded our 
experiments with an assessment of sinoatrial nodal physiology using confocal 
microscopy imaging of calcium flux and electrophysiology studies. 
 
Materials and Methods 
Ethics Statement/Cell Isolation and Expansion 
CPCs were isolated from cardiac tissue of neonates (1 day – 1 month), as 
previously described (Fuentes, 2013). The Institutional Review Board of Loma Linda 
University approved the protocol for use of tissue that was discarded during 
cardiovascular surgery, without identifiable private information, for this study with a 
waiver of informed consent. Briefly, atrial tissue was cut into small clumps 
(approximately 1.0 mm3) then enzymatically digested using collagenase (Roche, 
Indianapolis, IN) at a working concentration of 1.0 mg/mL. The resulting solution was 
then passed through a 40-µm cell strainer. Cells were cloned in a 96-well plate by 
limiting dilution to a final concentration of 0.8 cells per well to create populations for 
expansion. Cells were then screened for the co-expression of Isl1 and c-Kit. Clonal CPC 
cultures were selected for other markers of early cardiac development (KDR and 
PDGFRA) and then supplemented with growth media comprised of 10% fetal bovine 
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serum (Thermo Scientific, Waltham, MA), 100 µg/mL penicillin-streptomycin (Life 
Technologies, Carlsbad, CA), 1.0% minimum essential medium non-essential amino 
acids solution (Life Technologies, Carlsbad, CA), and 22% endothelial cell growth media 
(Lonza, Basel, Switzerland) in Medium 199 (Life Technologies, Carlsbad, CA). 
Mycoplasma contamination was tested using the MycoAlert Mycoplasma Detection Kit 
(Lonza, Basel, Switzerland) following the manufacturer’s protocol.  
 
Angiotensin II Dilution and Dosage Titration 
 Angiotensin II (Sigma Aldrich, St. Louis, MO) was dissolved in cell culture grade 
water and added to CPC growth media at concentrations of 1, 5, and 10 µM for 48, 72, 
and 168 hours. The induction of TBX3 and HCN4 expression was measured via RT-PCR 
and flow cytometry at all concentrations to determine that 10 µM of angiotensin II for 72 
hours was the optimal treatment condition.  
 
RNA Purification and cDNA Synthesis 
 Neonatal CPCs that were treated with angiotensin II were fixed in RNA Protect 
(Qiagen, Valencia, CA). RNA was purified from the RNA Protect samples using the 
RNeasy Mini Kit (Qiagen, Valencia, CA), per the manufacturer’s instructions. cDNA 
was prepared using 2 µg of RNA with Superscript III (Life Technologies, Carlsbad, CA) 
and used for gene expression analysis in quantitative RT-PCR experiments, as described 
below. 
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Quantitative RT-PCR 
Quantitative real-time polymerase chain reaction was performed using Go-Taq® 
qPCR Mastermix (Promega, Madison, WI) and the iCycler iQ™5 PCR Thermal Cycler 
(Bio-Rad, Hercules, CA) following a protocol of 94°C for 10 minutes followed by 45 
cycles of 94°C for 15 seconds, 52–68°C (depending on the primer) for 60 seconds, and 
72°C for 30 seconds. RT-PCR products were visualized using 1–2% agarose gel 
electrophoresis and low mass DNA ladder (Invitrogen, Carlsbad, CA). Threshold cycle 
values were then analyzed for each individual clone using the comparative CT method 
(Schmittgen, 2008). 
Primers were designed using the National Center for Biotechnology Information 
Primer-BLAST program and obtained from Integrated DNA Technologies (Coralville, 
IA). Primers used in experiments are listed in Table 9. 
 
Flow Cytometry 
We used flow cytometry to measure the expression of Hcn4. Cells were labeled to 
detect Hcn4 (ab85023; Abcam, Cambridge, MA; clone: S114-10). Isotype controls were 
matched to the species, isotype, and conjugated fluorophore. Fluorescently labeled cells 
were analyzed using MACSquant analyzer (Miltenyi Biotec, Auburn, CA) and FlowJo 
software (FlowJo, Ashland, OR). Dead cells were gated out using forward-scatter and 
side-scatter gating. 
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Table 9. Primer pairs used in RT-PCR for SAN experiments (5’ to 3’) 
Gene Forward Sequence  Reverse Sequence  
ACTIN  
TTTGAATGATGAGCCTTCGTC
CCC 
GTCTCAAGTCAGTGTACAGGTA
AGC 
AGTR1 TGCCTCCTCGCCAATGATTC TGAAACTGACGCTGGCTGAA 
AGTR2 
GTGTTTAGGCACTAAGCAAG
CTG 
GCTAGTAGTGGCAAGGGTGG 
CAMK2A GTCCAGTTCCAGCGTTCAGTT GTGGGGATTCAGGATGGTGG 
GJA1 CATTAGGGGGAAGGCGTGAG AGTCAGTCAAATCCCCCAACC 
GJC1 GAGGTGGAGGAGAGGCGAG CCGAGCTGCCTTCTTGTCTG 
HCN4 CAGCCTCTTACGCCTGTTAC CCAGGAGTTGTTCACCATGTTG 
NKX2-5 CGCCGCTCCAGTTCATAG GGTGGAGCTGGAGAAGACAGA 
PLCG1 GCCCGACATCTGCCAAAGAA AGTCCATTGTCCACCACAAACT 
PRKCA TTTTCCCGGGCAACGACTC CGCACCCGGACAAGAAAAAG 
SHOX2 CTTACGGCGTTCGTCTCCAA GACACCTCCGTCAGTCGC 
TBX18 GGTGGCAGGTAATGCTGACT ACTTGCATTGCCTTGCTTGG 
TBX3 TGGCCTACCATCCGTTCCTA GGACATCCACTGTTCCCCAG 
TBX5 CTCAGTCCCCCGGAACAAC CACGTACCTCCCAGCTCAAG 
TNNT2 
GTGGGAAGAGGCAGACTGA
G ATAGATGCTCTGCCACAGC 
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Protein Simple 
Following treatment with angiotensin II and detachment, CPCs were 
homogenized using RIPA buffer containing phosphatase inhibitor cocktail (Millipore, 
Temecula, CA), followed by centrifugation at 14,000 g for 15 minutes at 4°C and 
collection of the supernatant for analysis. Total protein concentrations were determined 
using the Pierce Micro BCA Protein Assay Kit (Thermo Scientific, Rockford, IL). A 
capillary-based western blotting system (ProteinSimple Wes, San Jose, CA) was used to 
assess protein expression. All procedures were completed according to the 
manufacturer’s instructions and default settings. Mouse, anti-Hcn4 antibody (1:10; cat 
no. ab85023; Abcam, Cambridge, MA; clone: S114-10) and mouse IgG2b, anti-human β-
Actin (1:50; cat no. 3700; Cell Signaling Technology, Danvers, MA; clone: 8H10D10) 
were used with the anti-mouse detection module from ProteimSimple. All data were 
analyzed with the Compass Software associated with the Wes instrument (ProteinSimple, 
San Jose, CA). Data were exported to Prism for further analysis, as described below.  
 
Calcium Handling Analysis 
 Fifty micrograms of Fluo4-AM dye (Life Technologies, Carlsbad, CA) was 
dissolved in pluronic acid and 20% DMSO (Life Technologies) via sonication before 
being resuspended in M199-supplemented growth media. Angiotensin II-treated CPCs 
were then incubated with the dye for 1 hour and imaged using a LSM 710 NLO laser-
scanning, confocal microscope (Carl Zeiss Microscopy Gmblt, Jena, Germany) at a 20× 
objective. All experiments were conducted at room temperature and in the absence of 
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external electrical stimulation. Images were processed using ImageJ (v.1.49, 
NIH, http://imagej.nih.gov/ij). 
 
Electrophysiology 
 For electrophysiological characterization of sinoatrial nodal cells, angiotensin II-
treated CPCs were seeded onto gelatin-coated coverslips and allowed to attach overnight 
in CPC growth media. The action potentials of the sinoatrial nodal cells were then 
measured in current-clamp mode at a 5 KHz sampling rate (Axopatch 1D, Molecular 
Devices, San Jose, CA) and analyzed using AxoGraph. Borosilicate glass 
microelectrodes were used with tip resistances of 5–8 MΩ when filled with pipette 
solution. Spontaneous action potentials were recorded at 25°C using the perforated 
patch method. Briefly, 10 µL of 50 mg/ 50 µL amphoteracin B (Sigma-Aldrich, St. 
Louis, MO) in molecular biology grade DMSO (Corning, Corning, NY) was added to 1 
mL of pipette solution, containing (mM): K-gluconate 130, Na-gluconate 10, NaCl 4, 
HEPES 10, GTP-NaꞏH2O 0.3, and ATP-MgꞏH2O 4 (pH 7.4, adjusted with NaOH). The 
bath solution contained (mM): NaCl 136, KCl, 5, MgCl2ꞏ6H2O 1, NaH2PO4ꞏ2H2O 0.3, 
CaCl2ꞏ2H2O 1.8, D-glucose 10, HEPES 10 (pH 7.3, adjusted with NaOH).  
 
Epinephrine Dilution 
To test the responsiveness of CPC-differentiated sinoatrial nodal cells to 
autonomic stimulation, bath solution was spiked to a working concentration of 5.5 µM 
epinephrine (Lot: BCBK3982V; Sigma-Aldrich, St. Louis, MO), as described in 
Taniguchi et al. (1981). Then, the membrane potential was recorded as described above. 
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Statistical Analysis 
The Shapiro-Wilk test for normality was used to test the normality of data 
distribution. We then performed a two-tailed, paired t-test to compare the mean of all 
normally distributed data. Non-normally distributed data were compared using a 
Wilcoxon matched-pairs signed rank text. All data are reported as the mean ± the 
standard error of the mean. Prism 7 version 7.02 (GraphPad, La Jolla, CA) was used for 
all statistical analyses. P values < 0.05 were assumed to indicate statistical significance.  
 
Results 
Angiotensin II Receptor Type I Activation Induces  
Calcium Signaling Gene Expression 
 To activate calcium signaling in neonatal CPCs using angiotensin II, we first 
screened for the type 1 receptor, which functions via a G-protein coupled receptor to 
activate protein kinase C activation and calcium potentiation (Venema, 1998). Since the 
type 2 receptor is widely speculated to antagonize the type 1 receptor via 
heterodimerazation (AbdAlla et al., 2001), we also screened CPCs to select neonatal 
clones that primarily expressed the type 1 receptor (Figure 29A). Then, we treated cells 
expressing this receptor with angiotensin II for 72 hours and measured the induction of 
genes related to calcium signaling (Figure 29B): PLCG1 (3.613 ± 0.008-fold change, 
P<0.001, n=3), PRKCA (7.493 ± 0.295-fold change, P<0.001, n=3), and CAMK2A (55.06 
± 9.986-fold change, P<0.01, n=3). 
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Figure 29. Neonatal cardiovascular progenitor cells expressing the type 1 angiotensin 
II receptor exhibit calcium activation following treatment with angiotensin II 
Neonatal cardiovascular progenitors were screened for the expression of the type 1 
angiotensin II receptor (AGTR1) using PCR and gel electrophoresis. The clone that 
expressed a higher ratio of the type 1 to type 2 (AGTR2) receptor (yellow box) was selected 
for further experiments (A). Then, CPCs with this receptor were treated with angiotensin 
II for 72 hours and calcium signaling gene expression was induced (B). n=3–6; **p<0.01, 
***p<0.001. Changes in gene expression are shown as the mean ± S.E.M. 
 
 
 
AGTR2 
ACTIN 
AGTR1 
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Treatment of Neonatal Cardiovascular Progenitor Cells with Angiotensin II Induces 
Expression of Sinoatrial Nodal Gene Program and Hcn4 Protein 
 Neonatal CPCs expressing the type I angiotensin II receptor were treated with 
angiotensin II for 72 hours. Changes in gene expression indicated the induction of the 
sinoatrial nodal gene program (Figure 30A): TBX3 (2.613 ± 0.2781-fold change, P<0.01, 
n=3), TBX5 (1.456 ± 0.224-fold change, P=0.152, n=3), TBX18 (1.901 ± 0.025-fold 
change, P<0.01, n=3), SHOX2 (2.273 ± 0.208-fold change, P<0.01, n=3), HCN4 (4.135 ± 
0.495-fold change, P<0.001, n=12),and GJC1 (Cxn 45; 2.482 ± 0.256-fold change, 
P<0.05, n=3). Meanwhile, the cardiomyocyte gene program was repressed (Figure 30B): 
NKX2-5 (0.197 ± 0.025-fold change, P<0.001, n=9), TNNT2 (0.645 ± 0.087-fold change, 
P<0.05, n=3), and GJA1 (Cxn 43; 2.482 ± 0.256-fold change, P<0.05, n=3). To confirm 
the induction of Hcn4 protein, which carries the funny current that is characteristic of 
pacemaker cells, we performed flow cytometry (Figure 30C) and western blot (Figure 
30D). We observed a 7.75 ± 0.085-fold change in Hcn4 protein expression (Figure 30E). 
 
Angiotensin II-Treated Cardiovascular Progenitor Cells  
Exhibit Auto-rhythmic Calcium Flux 
 To test whether induced Hcn4 protein impacted the physiology of neonatal CPCs, 
we incubated treated cells with Fluo4-AM to detect calcium flux. We observed the 
generation of spontaneous auto-rhythmic calcium flux (Figure 31) in treated (black dots) 
CPCs. Such calcium activity was not observed in untreated (red dots) CPCs. (n=8 per 
group). Among treated CPCs, two trends emerged in spontaneous rhythm generation, as 
indicated by black and blue trend lines.  
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Figure 31. Angiotensin II treatment induces auto-rhythmic calcium flux 
Neonatal cardiovascular progenitors were treated with angiotensin II for 72 hours, 
incubated with Fluor4-AM, and imaged using confocal microscopy. The intensity of 
calcium levels is indicated by the level of fluorescence. Black dots represent angiotensin 
II-treated CPCs, with black and blue lines representing the two observed calcium flux 
patterns. Red dots represent control CPCs. n=8 per group.  
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Angiotensin II-Treated Cardiovascular Progenitor Cells 
Have Functional Characteristics of Pacemaker Cells 
 Given that cardiomyocytes and various cardiac conduction system cell types (e.g., 
Purkinje fiber cells and atrioventricular node) exhibit auto-rhythmic currents, we 
performed whole cell electrophysiology recordings using the perforated patch method. 
Recording of angiotensin II-treated cells revealed an action potential of -40 ± 1 mV (n=9, 
Figure 32A), a slow maximum upstroke velocity (dV/dtmax < 10 V/s), and an epinephrine  
sensitivity that accelerated the number of action potentials from 1.05 ± 0.05 to 1.41 ± 
0.05 per second (P<0.001, n=8; Figure 32B). Interestingly, the action potential duration at 
50% of the maximum amplitude (APD50) of angiotensin II-treated CPCs was 289 ± 16 
ms, which was relatively longer than the APD50 of SAN-like cells documented in Protze 
et al. (2017). This was possibly due to the difference in temperature at which recordings 
were performed (25°C versus 37°C). Notably, no sponteanously depolarizing membrane 
potential was observed in untreated CPCs 
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Figure 32. Pacemaker cell functional characteristics are induced in neonatal CPCs 
following angiotensin II treatment 
The electrophysiology of neonatal cardiovascular progenitors that were treated with 
angiotensin II for 72 hours was recorded in the whole-cell, perforated-patch configuration. 
Representative membrane potential curves before and after filtering are shown as well as 
an analysis of action potential and maximum upstroke velocity (A). Epinephrine treatment 
reduced the time required to generate an action potential, as shown in a representative 
filtered membrane potential curve and by the increased number of action potentials per 
second (B). n=8–9; ***p<0.001. Change in the action potential count is shown as the mean 
± S.E.M. AP, action potential; APD50, action potential duration at 50% of the maximum 
amplitude; SAN, sinoatrial node 
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6000 ms 
70
 m
V
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Discussion 
In activating calcium signaling using angiotensin II, we were able to reliably 
direct the induction of the sinoatrial nodal gene program, which correlated to elevated 
Hcn4 protein expression and auto rhythmic calcium flux. Using angiotensin II to activate 
calcium signaling follows from similar findings in our early population of neonatal 
cardiovascular progenitors that were treated with hWnt5a or exposed to simulated 
microgravity. This latter cell culture method has been shown to induce the sinoatrial 
nodal gene program in neonatal CPCs (Baio, 2018) and neural crest progenitor cells 
(Hatzistergos, 2018). Interestingly, non-canonical Wnt signaling, particularly Wnt11, is 
critically involved in the regulation of neural crest cell development and migration (De 
Calisto, 2005) along with the induction of CD166 (Gessert, 2006), which marks the 
precursor population of sinoatrial nodal cells (Scanone, 2013). Thus, the use of 
angiotensin II to induce non-canonical Wnt/Ca2+ signaling in early neonatal 
cardiovascular progenitor cells logically follows from the observed activation of calcium 
signaling under microgravity and the ability of non-canonical Wnt to enrich the sinoatrial 
nodal precursor population. These findings merit further research into the mechanisms 
governing the early events of sinoatrial node development, which will enable the ultimate 
construction of a biological pacemaker. 
Recent work by the laboratories of Keller (Protze, 2017) and Foley (Brown, 2017) 
has produced important advances in the field of sinoatrial nodal development. Either 
overexpression of the TGFβ-activated kinase MAP3K7 (Brown, 2017) and Bmp4 
titration at the onset of cardiogenic mesoderm induction (Protze, 2017) were used to 
create sinoatrial nodal-like cells. Interestingly, working cardiomyocytes, which exhibit 
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high contractility, exhibit a morphology that differs from that of sinoatrial nodal cells 
(Bakker, 2010). However, the enriched population of SAN-like cardiomyocytes 
generated by Protze et al. (2017) follows from observations in other laboratories that such 
cells can be produced in smaller percentages as a byproduct of inducing ventricular 
cardiomyocytes from ESCs using a standard protocol of temporally regulated 
moprhogens (Jha, 2016). Meanwhile, several working myocardial genes were found to be 
repressed in Map3k7-overepxressing ESCs, supporting the work of Brown et al. (2017) in 
generating sinoatrial nodal-like cells that are distinct from pacemaker-like 
cardiomycoutes. Future work is needed to clarify whether such cells are functionally 
capable of serving as a biological pacemaker over a prolonged period of time, or whether 
they will revert into a ventricular- or atrial-like cardiomyocyte upon transplantation. 
Nevertheless, the use of human-derived CPCs as seeds for the development of an ex vivo 
sinoatrial node is possible. 
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CHAPTER FIVE 
COMMENTS 
 
 In this dissertation, we presented findings of the effects of reduced gravity 
conditions on neonatal cardiovascular progenitor cells. In this concluding chapter, we 
seek to summarize some of the most salient features of our experiments in three areas: 
molecular changes borne by spaceflight, their Earth applications, and sinoatrial nodal 
development. Through the experiments described herein, we have been able to uncover 
features of the molecular response of early cardiovascular progenitor cells to reduced 
gravity conditions. Importantly, these findings contribute to the broad understanding of 
how humankind will fare in deep space and provide guidance for the expansion of our 
species beyond Earth. Moreover, features of the adaptive response exhibited by CPCs 
under simulated microgravity and aboard the ISS suggest augmented therapeutic 
potential, as indicated by enhanced proliferation, migration, and stemness marker 
expression. These features may continue to be explored and tested on Earth and in space 
in an effort to translate these findings into demonstrably effective stem cell-based 
cardiovascular regeneration and therapies. In this dissertation, we have already applied 
this strategy to the early stages of biological pacemaker development. Future work can 
extend these incipient experiments to expand the utility of CPCs in regenerative medicine 
on Earth. 
As defined in chapter 2, the profound changes in developmental gene expression 
and enhanced proliferative potential experienced by CPCs during culture aboard the ISS 
are suggestive of augmented therapeutic potential on Earth. This prompted us to identify 
the molecular mechanisms by which CPCs adapt to reduced gravity conditions and to 
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understand how these effects could be recapitulated in vitro under normal gravity 
conditions. In doing so, we found that reduced mechanotransduction coupled with 
calcium signaling in a population of early cardiovascular progenitors can induce the 
expression of a modestly earlier developmental profile, as described in chapter 3. Finally, 
given that sinoatrial nodal cells are theorized to represent embryonic myocardium 
maintained in an undifferentiated state, we sought to understand whether the same 
signaling events that could induce an earlier developmental state under reduced gravity 
conditions could be applied to promote the development of pacemaker cells (chapter 4). 
When considered together, these studies advance our knowledge of the mechanisms 
governing the molecular adaptation to spaceflight and provide a plausible method for 
improving stem cell therapies and for inducing biological pacemaker cells.  
   
Summary and Future Directions 
 The findings described in this dissertation provide novel insights into the 
molecular events underpinning cardiac stem cell function beyond the Earth-bound 
context. Yet, further research is needed to ensure the safe and effective application of 
these mechanistic findings in future clinical therapies. Moreover, the observations that 
simulated microgravity can result in the abnormal accumulation of pacemaker cells 
(Hatzistergos, 2018) along with an induction of the sinoatrial nodal gene program (Baio, 
2018) merit further research into the incipient molecular events of the sinoatrial node’s 
development. In these concluding remarks, we contextualize the findings described 
throughout this dissertation by discussing ongoing and future efforts to understand 
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cardiovascular development and how primordial cardiac cells can be used to facilitate 
regeneration following injury. 
 
Reduced Gravity Conditions Impact Cardiogenesis 
As humankind has expanded our presence in low Earth orbit and aims to 
undertake missions to deep space, organ system-wide changes have been observed within 
astronauts. In addition to bone loss, muscular atrophy, impairment of the immune system, 
and deformations in the ocular system, the cardiovascular system has been observed to 
undergo remodeling and reduced function in response to spaceflight (Frippiat, 2016; 
White, 2001). Researchers have moved to study these effects at a single cell level so as to 
develop approaches that improve the likelihood of human survival in deep space. As 
these studies have evolved, the potential use of microgravity in maintaining or enhancing 
the pluripotent capabilities of cells has benefited subsequent directed differentiation upon 
mechanical reloading.  
 A recent review of tissue engineering under microgravity conditions has 
demonstrated the increasing interest in leveraging the reduced gravity environment of 
various simulators or the ISS to prepare preliminary vessels, eye tissue, bone cartilage, 
and multicellular cancer spheroids (Grimm, 2018). Despite the apparent benefits of 
microgravity-inspired stem cell research, few studies have applied space research to 
cardiac progenitors or cardiac differentiation (Frippiat, 2016; White, 2001). Although 
several studies have successfully developed primitive vessels (Pietsch , 2017; Grimm, 
2009; Grimm, 2010; Ma, 2014) from endothelial precursors (EA.hy926 or human cardiac 
microvascular endothelial cell types), only recently have researchers turned to studying 
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enhanced cardiomyocyte production (Jha, 2016) and augmented cardiac precursor  
stemness (Fuentes, 2015) under conditions of microgravity. Thus, our study of the effects 
of spaceflight on cardiovascular progenitors represents an important advance not only for 
cardiac adaptation and development in space, but also for identifying key mechanisms 
involved in the enhanced stemness that may represent a foundation for future methods of 
generating cardiac tissue.  
In summary, we found that microgravity exerts broad effects on the 
developmental status, proliferative potential, and migratory ability of CPCs, some of 
which occurred in an age-dependent manner. In particular, neonatal CPCs exhibited 
increased expression of early developmental markers, enhanced proliferative potential, 
and increased migratory capacity following spaceflight. These findings suggest that broad 
cytoskeletal modifications resulting from reduced mechanotransduction impart improved 
migratory and adhesion capabilities and that CPCs can propagate or experience additional 
intracellular signaling events (e.g., calcium signaling) that modify their developmental 
status. Until now, most studies of cardiovascular adaptation to spaceflight have focused 
on terminal cardiomyocytes or organ system-wide alterations (Hughson, 1985; Blue, 
2015; Hughson, 2017; Negishi, 2017). Conversely, studies of stem cells have focused 
largely on embryonic or induced pluripotent stem cells (Blaber, 2015; Shinde, 2016; Jha, 
2016). Thus, our findings provide unique information on the effects of spaceflight on 
cardiac lineage development. In the context of cardiovascular stem cell therapy, these 
results represent one avenue by which to procure a cardiac-committed stem cell with 
enhanced regenerative properties. This follows from increasingly strong evidence that 
supports the use of progenitors that are only nascent in their commitment to the 
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cardiovascular lineage in promoting cardiovascular repair. Thus, research in 
cardiovascular regenerative medicine must also consider methods that enhance the 
regenerative potential of CPCs. 
 In a study of repair following myocardial infarction in non-human primates, Blin 
et al. (2010) studied the efficacy of an early-stage cardiovascular progenitor that 
expressed stage-specific embryonic antigen 1 (SSEA-1), mesoderm posterior 1 (MESP1), 
and OCT4. In doing so, the researchers observed differentiation of these early cells into 
ventricular cardiomyocytes, thereby healing approximately 20% of the scar tissue. The 
use of such a progenitor was demonstrated to be efficacious in a rodent model of 
myocardial repair (Bellamy, 2015).  Meanwhile, Menasché et al. (2015) reported the first 
clinical case report of treatment using this early cardiovascular progenitor cell type. In 
brief, transplantation of SSEA-1- and Islet1-expressing CPCs derived from embryonic 
stem cells resulted in improved cardiovascular function. As shown in Table 2, studies of 
stem cell-based cardiovascular repair have revealed an emerging pattern in which an 
earlier cardiovascular progenitor more effectively improves cardiovascular function.  
 As future research into cardiovascular progenitor adaptation to spaceflight 
evolves, key questions must be answered. First, what are the most critical signaling 
components that account for the CPC response to spaceflight and subsequently enhanced 
stemness? Second, can these effects be recapitulated in vitro on Earth in the absence of 
simulated microgravity or ISS-borne laboratories? Although these questions have been 
addressed, at least in part, through our work in this dissertation, further questions persist. 
What is the optimal “dose” of microgravity for stem cell-based repair and, as a corollary, 
does low Earth orbit (e.g., the ISS) and deep space (e.g., a mission to Mars) produce the 
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same effects? Finally, what implications do these findings have for cardiac development 
in the context of extraterrestrial conception and in utero development? We are only 
beginning to uncover the wide-ranging implications of spaceflight for human biology. 
 
Signaling Events Involved in CPC Adaptation  
to Spaceflight Can Be Applied on Earth 
 As described above, the molecular mechanisms underpinning the adaptation of 
CPCs to spaceflight and simulated microgravity will facilitate the enhanced use of these 
cell types in ground-based therapies. Thus, we worked to identify the involvement of key 
signaling pathways in this process. As summarized below, the involvement of calcium 
and Akt signaling in primordial cardiovascular cells are critical to this process.  
In the context of cardiogenesis, studies performed in both embryos and ESC-
derived cardiomyocytes have shown a critical role of Ca2+ in regulating multiple steps of 
heart formation (Pucéat, 2005). For example, induction of Ca2+ oscillation promotes 
proliferation and, upon transplantation, enhances engraftment and expansion (Ferreira-
Martins, 2009). In this way, our observed shift in expression of markers of early cardiac 
development is likely the result, at least in part, of modified calcium signaling activity 
within neonatal CPCs. Furthermore, research into Mesp1-expressing pre-cardiac 
mesoderm derived from human ESCs identified enriched activity along the calcium, 
extracellular matrix-receptor, and Wnt signaling pathways at day 5 of development (den 
Hartogh, 2016), which is supported by our observed increase in markers of such a state of 
development after culture aboard the ISS (chapter two) and using SMG (Baio, 2018). 
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Interestingly, the ability of spaceflight to impact epigenetic regulation is only in 
its nascent stages of study, but, when further understood, may provide insights into the 
mechanisms governing enhanced differentiation potential under conditions of 
microgravity. In human lymphoblastoid cells, DNA methylation patterns were found to 
be widely altered by simulated microgravity (Chowdhury et al, 2016), with Singh et al. 
(2010) reporting that simulated microgravity preferentially induces hypomethylation in 
human lymphocytes. It could be speculated that microgravity can induce 
hypomethylation in cardiovascular progenitor cells, and further study in this area 
represents one interesting avenue for future research. As demonstrated in this 
dissertation, cardiomyocytes were induced from CPCs using treatment with 5-
azacytidine, which inhibits DNA methyltransferase and results in near global 
hypomethylation. While the exact mechanism of this treatment is unknown, Notch-
related signaling components, which promote cardiomyocte induction by inhibiting 
canonical Wnt signaling during the early stages of cardiogenesis (Gessert & Kühl, 2010), 
remain uniquely hypomethylated following removal of 5-azacytidine from cell culture 
(Ramos et al., 2015) suggesting that hypomethylation events are important to 
differentiation processes. Thus, the role of microgravity-induced alterations in epigenetic 
control of stem cells, and of methylation events in particular, merits further study.  
In addition to identifying the role of calcium signaling in mediating some of the 
changes experienced by neonatal CPCs, we also found that spaceflight impacted adult 
CPCs in a manner that may not yet be fully appreciated. Therefore, the mechanisms of 
CPC biology appear to be age-dependent. The findings outlined in this dissertation can be 
used to guide future experiments that characterize such changes and ultimately develop 
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therapies that can enable the use of adult-derived CPCs in an autologous manner. Recent 
work in our own laboratory (Fuentes, 2013) has identified functional differences in 
signaling pathways pertinent to many of the processes observed under simulated 
microgravity. Similarly, the secretome of adult and neonatal CPCs were recently 
compared using liquid chromatography tandem mass spectrometry (Sharma, 2017). In 
this study, researchers identified elevated protein expression in pathways related to stem 
cells maintenance, differentiation, heat shock proteins (i.e., stress response), 
proliferation/growth, anti-apoptosis, and calcium regulation in tissue culture media of 
neonatal CPCs. Conversely, tissue culture media of adult CPCs was found to be enriched 
in proteins related to aging, senescence, and anti-proliferation.  
This prompts an important line of inquiry to understand the molecular basis for 
functional differences between adult- and neonate-derived cardiovascular progenitor 
cells. While we have shown here that CPCs derived from both age populations can 
similarly express developmental markers and exhibit an ability to differentiate (though to 
differing extents), their functional differences in response to various conditions, including 
simulated microgravity (Fuentes, 2015), spaceflight, hypoxia (Hernandez, 2018), and 
myocardial infarction (Sharma, 2017), indicate fundamental differences in the 
mechanisms governing age-dependent CPC function.  
Notably, both Sharma et al. (2017) and Hernandez et al. (2018) detected a 
difference in the induction of heat shock proteins between neonatal and adult CPCs. 
Moreover, the former research group demonstrated that heat shock factor 1 is an 
upstream regulator of many of the pathways uniquely enriched in the neonatal CPC 
secretome. Thus, the age-dependent response of CPCs to various conditions, including 
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spaceflight, may be a reflection of the age-dependent readiness of cells to mount a stress 
response and induce down-stream effects. Experiments that assess the delayed response 
of adult CPCs to spaceflight may refine this hypothesis and provide a plausible path for 
enhancing the utilization of adult patient-derived cells. This is particularly important 
given that adult patients would more regularly require regenerative therapies for the 
heart.  
 Ultimately, future research will continue to uncover the utility of microgravity-
treated CPCs in cardiovascular repair. Our observed enhancements in migration and 
proliferation along with the induction of an earlier developmental state compliment the 
emerging trend of early cardiac progenitor cell transplantation. As we have elucidated the 
involvement of key signaling pathways in the process of CPC adaptation to spaceflight, 
we can begin to leverage the observed enhanced therapeutic potential of spaceflown or 
simulated microgravity-exposed cardiac progenitors on Earth. As shown in this 
dissertation, one unique application of such findings is the development of an in vitro 
biological pacemaker. 
 
The Sinoatrial Node Can Be Induced  
in Early Neonatal Cardiovascular Progenitor Cells 
Some astronauts experience arrhythmias during spaceflight (Anzai, 2014). The 
mechanisms by which these irregularities in heart rhythm develop are unknown, but 
researchers speculate that diet imbalance and neurohormonal dysregulation are possible 
causes. Among the latter, regulators of heart rhythm, such as angiotensin II (Delpón, 
2005; Watenpaugh, 2001; Xu, 2009), are differentially regulated by spaceflight and merit 
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further attention. Reduced gravity conditions have also been implicated in the 
dysregulation of myocardial and sinoatrial nodal gene program expression in endogenous 
progenitors. Indeed, simulated microgravity has been shown to induce the sinoatrial 
nodal gene program in neonatal CPCs (Baio, 2018) and neural crest progenitor cells 
(Hatzistergos, 2018). Such alterations to cardiac pacing and progenitor developmental 
gene expression under reduced gravity prompted us to further explore the means by 
which signaling events under these conditions may promote sinoatrial nodal 
development. Interestingly, non-canonical Wnt signaling, particularly Wnt11, is critically 
involved in the regulation of neural crest cell development and migration (De Calisto, 
2005) along with the induction of CD166 (Gessert, 2006), which marks the precursor 
population of sinoatrial nodal cells (Scanone, 2013). Thus, the use of angiotensin II to 
induce non-canonical Wnt/Ca2+ signaling in early neonatal cardiovascular progenitor 
cells logically follows from the observed activation of calcium signaling under 
microgravity and the ability of non-canonical Wnt to enrich the sinoatrial nodal precursor 
population. Furthermore, the induction of TGFB1 expression under SMG (Baio, 2018) 
also supports the observation that Tgfβ-activated kinase signaling in embryonic stem 
cells faithfully induces functional sinoatrial nodal cells (Brown, 2017).   
When considered together, this evidence suggests that sinoatrial nodal induction 
requires a sufficiently developmentally early cell type. This is supported by observations 
by Bressan et al. (2013), who traced sinoatrial nodal development in an avian model and 
found that the SAN developed from a tertiary heart field that did not express Nkx2-5 or 
Isl1. Importantly, early mesodermal cues were able to promote the development of this 
specialized region shortly after gastrulation, prior to the onset of cardiac morphogenesis. 
 175 
This is reflected by the nearly unanimous use of embryonic or induced pluripotent stem 
cells in engineering biological pacemaker cells. Thus, our findings that angiotensin II 
treatment can induce the sinoatrial nodal gene program and elicit a sinoatrial nodal-like 
phenotype in CPCs provides plausible evidence that a sufficiently developmentally early 
cardiovascular progenitor may be suitable for pacemaker cell induction. 
Importantly, further work must be performed to determine if angiotensin II-
treated cells can retain a SAN-like phenotype beyond the period of treatment and, 
ultimately, following transplantation and integration into the host myocardium.  Other 
laboratories have induced a sinoatrial nodal-like phenotype by transforming ventricular 
myocytes in a pig and guinea pig with TBX18 transfection using an adenoviral vector (Hu 
et al., 2014; Kapoor et al, 2013). In these studies, researchers observed a decline in 
pacemaking efficacy approximately two weeks after injection, which was speculated to 
be the result of immune-mediated clearance of the adenovirus. Meanwhile, in fetal mice, 
TBX18 was found to be insufficient to induce SAN differentiation of chamber 
cardiomyocytes, thereby suggesting that the transcription factor may be relevant to 
sinoatrial nodal development, but not specific to its fate nor sufficient for its induction 
(Greulich et al., 2016). This complicates our ability to accept the reliability of TBX18 
induction as being sufficient for sustained sinoatrial nodal reprogramming. Furthermore, 
recent work from the Keller group (Protze et al., 2017) demonstrated that functional SAN 
induction and subsequent integration following transplantation into rodents is possible, 
but similarly only assessed the in vivo efficacy after two weeks. Thus, longer-term studies 
(i.e., > 2 weeks) are needed to ensure that induced sinoatrial nodal cells are able to 
maintain their phenotype, successfully interdigitate with the surrounding working 
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myocardium, and serve as a reliable and non-arrhythmogenic pacemaker following 
transplantation.  
Meanwhile, work by the Foley group (Brown et al., 2017) demonstrated an 
important role of Tgfβ signaling early in development, which resulted in the induction of 
HCN4 within days of embryoid body formation. Interestingly, this follows from the 
identification of a distinct and temporally early population of mesoderm that gives rise to 
the sinoatrial node (Bressan et al., 2013). Furthermore, our finding that 72 hours of 
treatment with angiotensin II was sufficient to induce a pacemaker-like phenotype in a 
CPC population, as described in chapter four, overlaps with the timeline of HCN4 
induction in Brown et al. (2017). While Protze et al. (2017) and the TBX18 transfection 
studies either successfully reprogramed myocytes or induced cardiomyocytes into cells 
with pacing potential, these derivatives still retain features of cardiomyocytes and may 
therefore be susceptible to the extracellular environment of the surrounding myocardium 
following transplantation, which may revert sinoatrial nodal-like cardiomyocytes back 
into working cardiomyocytes. Although neither the Foley group nor our laboratory have 
tested SAN-like cells in vivo, doing so would be critical to test this hypothesis as both 
groups have prepared pacemaker-like cells that exhibit repression of working myocardial 
genes and may thus be able to sustain the pacemake phenotype beyond two weeks. 
Ultimately, these findings merit further research into the mechanisms governing 
the early events of sinoatrial node development, which will enable the ultimate 
construction of a biological pacemaker. Furthermore, the observed relationship between 
simulated microgravity/spaceflight and sinoatrial nodal gene program/pacemaker cell 
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accumulation indicate that pre-cardiovascular developmental stages, such as the incipient 
mesodermal or mesendodermal stages, merit further research.  
 
Conclusions 
As humans prepare to expand our presence in space, it is imperative to deepen our 
understanding of the nature of cellular adaptation to reduced gravity so that we may 
develop mechanisms by which these molecular changes in cardiac cell types can be 
countered. As experiments into the mechanisms governing human development and 
function in spaceflight evolve, it will be imperative to continue to apply these findings to 
regenerative therapies and tissue engineering. Ultimately, further exploration of the 
therapeutic potential of space-flown cardiovascular progenitor cells may one day yield 
substantial benefits for cardiac repair on Earth. 
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